SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'D16'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AXW_A_MTXA732_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 12 | LYS A 77ILE A 108LEU A 192ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258ALA A 312 | D16 A 414 ( 4.3A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.70A | 1axwA-1hvyA:39.1 | 1axwA-1hvyA:51.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AXW_A_MTXA732_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 12 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.90A | 1axwA-4iqqA:36.2 | 1axwA-4iqqA:44.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AXW_A_MTXA732_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ILE A 110LEU A 194LEU A 223GLY A 224PHE A 227 | D16 A 402 (-4.0A)NoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A) | 1.16A | 1axwA-4iqqA:36.2 | 1axwA-4iqqA:44.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AXW_A_MTXA732_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 12 | ILE A 132LEU A 216ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.0A)NoneD16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 1.07A | 1axwA-5h3aA:36.3 | 1axwA-5h3aA:47.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AXW_B_MTXB733_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 11 | LYS A 77ILE A 108TRP A 109ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258 | D16 A 414 ( 4.3A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.67A | 1axwB-1hvyA:38.9 | 1axwB-1hvyA:51.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AXW_B_MTXB733_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 11 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.89A | 1axwB-4iqqA:36.3 | 1axwB-4iqqA:44.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AXW_B_MTXB733_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 11 | ILE A 110TRP A 111LEU A 223GLY A 224PHE A 227 | D16 A 402 (-4.0A)NoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A) | 1.05A | 1axwB-4iqqA:36.3 | 1axwB-4iqqA:44.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AXW_B_MTXB733_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 11 | LYS A 79ILE A 110ASP A 220LEU A 223GLY A 224TYR A 260 | D16 A 402 ( 4.5A)D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 1.06A | 1axwB-4iqqA:36.3 | 1axwB-4iqqA:44.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AXW_B_MTXB733_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 11 | ILE A 132ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 0.89A | 1axwB-5h3aA:36.5 | 1axwB-5h3aA:47.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AXW_B_MTXB733_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 11 | ILE A 132TRP A 133GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.0A)NoneD16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 0.99A | 1axwB-5h3aA:36.5 | 1axwB-5h3aA:47.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1B02_A_C2FA281_0 (PROTEIN (THYMIDYLATESYNTHASE)) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 11 | ILE A 108TRP A 109LEU A 192ASP A 218LEU A 221GLY A 222TYR A 258ALA A 312 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.67A | 1b02A-1hvyA:34.9 | 1b02A-1hvyA:37.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1B02_A_C2FA281_0 (PROTEIN (THYMIDYLATESYNTHASE)) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 11 | ILE A 110ASP A 220LEU A 223GLY A 224TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 0.80A | 1b02A-4iqqA:31.7 | 1b02A-4iqqA:35.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1B02_A_C2FA281_0 (PROTEIN (THYMIDYLATESYNTHASE)) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 11 | ILE A 110LEU A 194LEU A 223GLY A 224TYR A 260 | D16 A 402 (-4.0A)NoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 1.08A | 1b02A-4iqqA:31.7 | 1b02A-4iqqA:35.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_A_D16A414_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 8 / 12 | GLU A 89ILE A 110ASN A 114ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | NoneD16 A 402 (-4.0A)NoneD16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.77A | 1hvyA-4iqqA:12.9 | 1hvyA-4iqqA:62.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_A_D16A414_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | GLU A 89ILE A 110TRP A 111ASN A 114PHE A 227 | NoneD16 A 402 (-4.0A)NoneNoneD16 A 402 (-3.2A) | 0.68A | 1hvyA-4iqqA:12.9 | 1hvyA-4iqqA:62.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_A_D16A414_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 8 / 12 | PHE A 104GLU A 111ILE A 132ASN A 136ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 (-3.6A)D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)NoneD16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 0.76A | 1hvyA-5h3aA:21.0 | 1hvyA-5h3aA:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_A_D16A414_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 12 | PHE A 104GLU A 111ILE A 132TRP A 133ASN A 136PHE A 249 | D16 A 401 (-3.6A)D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)NoneNoneD16 A 401 (-3.4A) | 0.63A | 1hvyA-5h3aA:21.0 | 1hvyA-5h3aA:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_B_D16B415_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 8 / 12 | GLU A 89ILE A 110ASN A 114ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | NoneD16 A 402 (-4.0A)NoneD16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.80A | 1hvyB-4iqqA:42.2 | 1hvyB-4iqqA:62.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_B_D16B415_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | GLU A 89ILE A 110TRP A 111ASN A 114PHE A 227 | NoneD16 A 402 (-4.0A)NoneNoneD16 A 402 (-3.2A) | 0.72A | 1hvyB-4iqqA:42.2 | 1hvyB-4iqqA:62.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_B_D16B415_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 7 / 12 | GLU A 111ILE A 132ASN A 136ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)NoneD16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 0.78A | 1hvyB-5h3aA:43.0 | 1hvyB-5h3aA:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_B_D16B415_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | GLU A 111ILE A 132TRP A 133ASN A 136PHE A 249 | D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)NoneNoneD16 A 401 (-3.4A) | 0.64A | 1hvyB-5h3aA:43.0 | 1hvyB-5h3aA:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_C_D16C416_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 8 / 11 | GLU A 89ILE A 110ASN A 114ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | NoneD16 A 402 (-4.0A)NoneD16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.61A | 1hvyC-4iqqA:13.1 | 1hvyC-4iqqA:62.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_C_D16C416_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 11 | GLU A 89ILE A 110TRP A 111ASN A 114PHE A 227 | NoneD16 A 402 (-4.0A)NoneNoneD16 A 402 (-3.2A) | 0.66A | 1hvyC-4iqqA:13.1 | 1hvyC-4iqqA:62.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_C_D16C416_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 8 / 11 | PHE A 104GLU A 111ILE A 132ASN A 136ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 (-3.6A)D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)NoneD16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 0.62A | 1hvyC-5h3aA:21.3 | 1hvyC-5h3aA:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_C_D16C416_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 11 | PHE A 104GLU A 111ILE A 132TRP A 133ASN A 136PHE A 249 | D16 A 401 (-3.6A)D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)NoneNoneD16 A 401 (-3.4A) | 0.62A | 1hvyC-5h3aA:21.3 | 1hvyC-5h3aA:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_D_D16D417_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 7 / 12 | GLU A 89ILE A 110ASN A 114LEU A 194LEU A 223GLY A 224PHE A 227 | NoneD16 A 402 (-4.0A)NoneNoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A) | 0.84A | 1hvyD-4iqqA:42.3 | 1hvyD-4iqqA:62.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_D_D16D417_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 7 / 12 | GLU A 89ILE A 110ASN A 114LEU A 223GLY A 224PHE A 227TYR A 260 | NoneD16 A 402 (-4.0A)NoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.73A | 1hvyD-4iqqA:42.3 | 1hvyD-4iqqA:62.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_D_D16D417_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 7 / 12 | GLU A 89ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | NoneD16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.70A | 1hvyD-4iqqA:42.3 | 1hvyD-4iqqA:62.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_D_D16D417_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 7 / 12 | GLU A 89ILE A 110TRP A 111ASN A 114LEU A 194LEU A 223PHE A 227 | NoneD16 A 402 (-4.0A)NoneNoneNoneD16 A 402 (-3.7A)D16 A 402 (-3.2A) | 0.94A | 1hvyD-4iqqA:42.3 | 1hvyD-4iqqA:62.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_D_D16D417_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 7 / 12 | GLU A 111ILE A 132ASN A 136LEU A 216GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)NoneNoneD16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 0.73A | 1hvyD-5h3aA:43.1 | 1hvyD-5h3aA:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_D_D16D417_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 12 | GLU A 111ILE A 132ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 0.56A | 1hvyD-5h3aA:43.1 | 1hvyD-5h3aA:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_D_D16D417_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 12 | GLU A 111ILE A 132TRP A 133ASN A 136LEU A 216PHE A 249 | D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)NoneNoneNoneD16 A 401 (-3.4A) | 0.69A | 1hvyD-5h3aA:43.1 | 1hvyD-5h3aA:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1I00_A_D16A315_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 9 | PHE A 80GLU A 87ILE A 108ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.8A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.53A | 1i00A-1hvyA:43.9 | 1i00A-1hvyA:98.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1I00_A_D16A315_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 5 / 9 | PHE A 80GLU A 87ILE A 108TRP A 109PHE A 225 | D16 A 414 (-3.7A)D16 A 414 (-3.8A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.6A) | 0.62A | 1i00A-1hvyA:43.9 | 1i00A-1hvyA:98.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1I00_A_D16A315_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 8 / 9 | GLU A 89ILE A 110TRP A 111ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | NoneD16 A 402 (-4.0A)NoneD16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.42A | 1i00A-4iqqA:42.1 | 1i00A-4iqqA:62.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1I00_A_D16A315_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 8 / 9 | PHE A 104GLU A 111ILE A 132TRP A 133ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 (-3.6A)D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)NoneD16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 0.35A | 1i00A-5h3aA:21.2 | 1i00A-5h3aA:70.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1I00_B_D16B409_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 9 | PHE A 80ILE A 108TRP A 109ASP A 218LEU A 221GLY A 222PHE A 225ASN A 226TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 (-3.0A)UMP A 314 ( 4.4A) | 0.65A | 1i00B-1hvyA:44.0 | 1i00B-1hvyA:98.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1I00_B_D16B409_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 7 / 9 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227ASN A 228TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)UMP A 401 (-3.3A)D16 A 402 ( 4.2A) | 0.29A | 1i00B-4iqqA:12.8 | 1i00B-4iqqA:62.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1I00_B_D16B409_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 7 / 9 | PHE A 104ILE A 132ASP A 242GLY A 246PHE A 249ASN A 250TYR A 282 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-3.2A)UMP A 402 (-4.5A) | 0.21A | 1i00B-5h3aA:21.0 | 1i00B-5h3aA:70.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1I00_B_D16B409_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 9 | PHE A 104TRP A 133PHE A 249ASN A 250TYR A 282 | D16 A 401 (-3.6A)NoneD16 A 401 (-3.4A)UMP A 402 (-3.2A)UMP A 402 (-4.5A) | 0.90A | 1i00B-5h3aA:21.0 | 1i00B-5h3aA:70.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JKH_A_EFZA999_1 (HIV-1 RT, A-CHAINHIV-1 RT, B-CHAIN) |
5a6b | N-ACETYL-BETA-D-GLUCOSAMINIDASE (Streptococcuspneumoniae) | 5 / 11 | VAL D 161CYH D 163TYR D 121TRP D 373TYR D 88 | NoneNoneNoneOAN D1627 (-3.7A)None | 1.50A | 1jkhA-5a6bD:undetectable1jkhB-5a6bD:1.4 | 1jkhA-5a6bD:22.661jkhB-5a6bD:19.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JU6_A_LYAA317_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 11 / 11 | PHE A 80ILE A 108TRP A 109ASN A 112ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258MET A 311ALA A 312 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A)D16 A 414 (-3.6A) | 0.78A | 1ju6A-1hvyA:46.8 | 1ju6A-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JU6_A_LYAA317_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 11 | ILE A 110ASN A 114LEU A 223GLY A 224PHE A 227 | D16 A 402 (-4.0A)NoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A) | 1.03A | 1ju6A-4iqqA:41.7 | 1ju6A-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JU6_A_LYAA317_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 11 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.91A | 1ju6A-4iqqA:41.7 | 1ju6A-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JU6_A_LYAA317_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 11 | PHE A 104ILE A 132ASN A 136GLY A 246PHE A 249 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)NoneD16 A 401 ( 3.2A)D16 A 401 (-3.4A) | 1.17A | 1ju6A-5h3aA:42.3 | 1ju6A-5h3aA:71.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JU6_A_LYAA317_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 11 | PHE A 104ILE A 132ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 0.95A | 1ju6A-5h3aA:42.3 | 1ju6A-5h3aA:71.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JU6_A_LYAA317_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 11 | PHE A 104ILE A 132TRP A 133ASN A 136PHE A 249 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)NoneNoneD16 A 401 (-3.4A) | 0.86A | 1ju6A-5h3aA:42.3 | 1ju6A-5h3aA:71.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JU6_B_LYAB315_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 9 | LYS A 77ILE A 108TRP A 109ASN A 112ASP A 218LEU A 221GLY A 222TYR A 258MET A 311 | D16 A 414 ( 4.3A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A) | 0.66A | 1ju6B-1hvyA:46.8 | 1ju6B-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JU6_B_LYAB315_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 9 | ILE A 110ASP A 220LEU A 223GLY A 224TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 0.75A | 1ju6B-4iqqA:41.8 | 1ju6B-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JU6_C_LYAC315_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 10 / 10 | ILE A 108TRP A 109ASN A 112ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258MET A 311ALA A 312 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A)D16 A 414 (-3.6A) | 0.81A | 1ju6C-1hvyA:46.8 | 1ju6C-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JU6_C_LYAC315_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 10 | ILE A 110ASN A 114LEU A 223GLY A 224PHE A 227 | D16 A 402 (-4.0A)NoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A) | 1.04A | 1ju6C-4iqqA:41.8 | 1ju6C-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JU6_C_LYAC315_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 10 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.91A | 1ju6C-4iqqA:41.8 | 1ju6C-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JU6_C_LYAC315_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 10 | ILE A 132ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 0.96A | 1ju6C-5h3aA:42.3 | 1ju6C-5h3aA:71.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JU6_D_LYAD315_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 11 / 11 | LYS A 77PHE A 80ILE A 108TRP A 109ASN A 112ASP A 218LEU A 221GLY A 222TYR A 258MET A 311ALA A 312 | D16 A 414 ( 4.3A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A)D16 A 414 (-3.6A) | 0.67A | 1ju6D-1hvyA:46.8 | 1ju6D-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JU6_D_LYAD315_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 11 | ILE A 110ASP A 220LEU A 223GLY A 224TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 0.76A | 1ju6D-4iqqA:41.8 | 1ju6D-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JU6_D_LYAD315_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 11 | PHE A 104ILE A 132ASP A 242GLY A 246TYR A 282 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)UMP A 402 (-4.5A) | 0.66A | 1ju6D-5h3aA:42.3 | 1ju6D-5h3aA:71.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_A_LYAA315_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 10 | ILE A 108TRP A 109ASN A 112ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258MET A 311 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A) | 0.84A | 1jujA-1hvyA:45.3 | 1jujA-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_A_LYAA315_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 10 | LYS A 77ILE A 108TRP A 109ASN A 112ASP A 218LEU A 221GLY A 222TYR A 258MET A 311 | D16 A 414 ( 4.3A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A) | 0.63A | 1jujA-1hvyA:45.3 | 1jujA-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_A_LYAA315_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 10 | ILE A 110ASN A 114LEU A 223GLY A 224PHE A 227 | D16 A 402 (-4.0A)NoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A) | 1.16A | 1jujA-4iqqA:41.3 | 1jujA-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_A_LYAA315_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 10 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.95A | 1jujA-4iqqA:41.3 | 1jujA-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_A_LYAA315_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 10 | LYS A 79ILE A 110ASP A 220GLY A 224TYR A 260 | D16 A 402 ( 4.5A)D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 0.91A | 1jujA-4iqqA:41.3 | 1jujA-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_A_LYAA315_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 10 | ILE A 132ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 1.03A | 1jujA-5h3aA:41.6 | 1jujA-5h3aA:71.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_B_LYAB315_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 10 | ILE A 108TRP A 109ASN A 112ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258MET A 311 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A) | 0.84A | 1jujB-1hvyA:45.3 | 1jujB-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_B_LYAB315_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 10 | LYS A 77ILE A 108TRP A 109ASN A 112ASP A 218LEU A 221GLY A 222TYR A 258MET A 311 | D16 A 414 ( 4.3A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A) | 0.63A | 1jujB-1hvyA:45.3 | 1jujB-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_B_LYAB315_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 10 | ILE A 110ASN A 114LEU A 223GLY A 224PHE A 227 | D16 A 402 (-4.0A)NoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A) | 1.16A | 1jujB-4iqqA:41.3 | 1jujB-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_B_LYAB315_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 10 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.95A | 1jujB-4iqqA:41.3 | 1jujB-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_B_LYAB315_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 10 | LYS A 79ILE A 110ASP A 220GLY A 224TYR A 260 | D16 A 402 ( 4.5A)D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 0.91A | 1jujB-4iqqA:41.3 | 1jujB-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_B_LYAB315_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 10 | ILE A 132ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 1.03A | 1jujB-5h3aA:41.5 | 1jujB-5h3aA:71.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_C_LYAC315_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 10 | ILE A 108TRP A 109ASN A 112ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258MET A 311 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A) | 0.84A | 1jujC-1hvyA:45.2 | 1jujC-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_C_LYAC315_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 10 | LYS A 77ILE A 108TRP A 109ASN A 112ASP A 218LEU A 221GLY A 222TYR A 258MET A 311 | D16 A 414 ( 4.3A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A) | 0.63A | 1jujC-1hvyA:45.2 | 1jujC-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_C_LYAC315_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 10 | ILE A 110ASN A 114LEU A 223GLY A 224PHE A 227 | D16 A 402 (-4.0A)NoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A) | 1.16A | 1jujC-4iqqA:41.3 | 1jujC-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_C_LYAC315_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 10 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.95A | 1jujC-4iqqA:41.3 | 1jujC-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_C_LYAC315_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 10 | LYS A 79ILE A 110ASP A 220GLY A 224TYR A 260 | D16 A 402 ( 4.5A)D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 0.91A | 1jujC-4iqqA:41.3 | 1jujC-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_C_LYAC315_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 10 | ILE A 132ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 1.03A | 1jujC-5h3aA:41.6 | 1jujC-5h3aA:71.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_D_LYAD315_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 10 | ILE A 108TRP A 109ASN A 112ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258MET A 311 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A) | 0.84A | 1jujD-1hvyA:45.3 | 1jujD-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_D_LYAD315_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 10 | LYS A 77ILE A 108TRP A 109ASN A 112ASP A 218LEU A 221GLY A 222TYR A 258MET A 311 | D16 A 414 ( 4.3A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A) | 0.63A | 1jujD-1hvyA:45.3 | 1jujD-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_D_LYAD315_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 10 | ILE A 110ASN A 114LEU A 223GLY A 224PHE A 227 | D16 A 402 (-4.0A)NoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A) | 1.16A | 1jujD-4iqqA:41.3 | 1jujD-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_D_LYAD315_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 10 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.95A | 1jujD-4iqqA:41.3 | 1jujD-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_D_LYAD315_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 10 | LYS A 79ILE A 110ASP A 220GLY A 224TYR A 260 | D16 A 402 ( 4.5A)D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 0.91A | 1jujD-4iqqA:41.3 | 1jujD-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_D_LYAD315_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 10 | ILE A 132ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 1.03A | 1jujD-5h3aA:41.6 | 1jujD-5h3aA:71.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1RTS_A_D16A309_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 8 | ILE A 108TRP A 109ASP A 218LEU A 221GLY A 222TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A) | 0.60A | 1rtsA-1hvyA:45.1 | 1rtsA-1hvyA:92.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1RTS_A_D16A309_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 7 / 8 | PHE A 80ILE A 108ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.50A | 1rtsA-1hvyA:45.1 | 1rtsA-1hvyA:92.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1RTS_A_D16A309_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 8 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.24A | 1rtsA-4iqqA:42.7 | 1rtsA-4iqqA:63.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1RTS_A_D16A309_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 8 | PHE A 104ILE A 132ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 0.26A | 1rtsA-5h3aA:43.7 | 1rtsA-5h3aA:70.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1RTS_B_D16B409_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 7 | ILE A 108ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.39A | 1rtsB-1hvyA:45.9 | 1rtsB-1hvyA:92.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1RTS_B_D16B409_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 7 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.30A | 1rtsB-4iqqA:43.2 | 1rtsB-4iqqA:63.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1RTS_B_D16B409_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 7 | ILE A 132ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 0.21A | 1rtsB-5h3aA:43.8 | 1rtsB-5h3aA:70.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TLS_A_C2FA266_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 12 | ILE A 108TRP A 109LEU A 192LEU A 221GLY A 222PHE A 225TYR A 258ALA A 312 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.85A | 1tlsA-1hvyA:39.5 | 1tlsA-1hvyA:51.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TLS_A_C2FA266_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ILE A 110LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.93A | 1tlsA-4iqqA:36.2 | 1tlsA-4iqqA:44.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TLS_A_C2FA266_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ILE A 110TRP A 111LEU A 194LEU A 223PHE A 227 | D16 A 402 (-4.0A)NoneNoneD16 A 402 (-3.7A)D16 A 402 (-3.2A) | 1.14A | 1tlsA-4iqqA:36.2 | 1tlsA-4iqqA:44.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TLS_A_C2FA266_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | ILE A 132TRP A 133LEU A 216GLY A 246PHE A 249 | D16 A 401 ( 4.0A)NoneNoneD16 A 401 ( 3.2A)D16 A 401 (-3.4A) | 1.08A | 1tlsA-5h3aA:36.3 | 1tlsA-5h3aA:47.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TLS_B_C2FB266_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 12 | ILE A 108TRP A 109LEU A 192LEU A 221GLY A 222PHE A 225TYR A 258ALA A 312 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.78A | 1tlsB-1hvyA:39.5 | 1tlsB-1hvyA:51.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TLS_B_C2FB266_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ILE A 110LEU A 194LEU A 223GLY A 224PHE A 227 | D16 A 402 (-4.0A)NoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A) | 1.14A | 1tlsB-4iqqA:36.3 | 1tlsB-4iqqA:44.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TLS_B_C2FB266_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ILE A 110LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.86A | 1tlsB-4iqqA:36.3 | 1tlsB-4iqqA:44.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TLS_B_C2FB266_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | ILE A 132LEU A 216GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.0A)NoneD16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 1.09A | 1tlsB-5h3aA:36.5 | 1tlsB-5h3aA:47.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TLS_B_C2FB266_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | ILE A 132TRP A 133LEU A 216GLY A 246PHE A 249 | D16 A 401 ( 4.0A)NoneNoneD16 A 401 ( 3.2A)D16 A 401 (-3.4A) | 1.06A | 1tlsB-5h3aA:36.5 | 1tlsB-5h3aA:47.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TSN_A_C2FA266_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 12 | ILE A 108TRP A 109LEU A 192LEU A 221GLY A 222PHE A 225TYR A 258ALA A 312 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.86A | 1tsnA-1hvyA:39.3 | 1tsnA-1hvyA:51.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TSN_A_C2FA266_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ILE A 110LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.93A | 1tsnA-4iqqA:36.1 | 1tsnA-4iqqA:44.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TSN_A_C2FA266_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 12 | ILE A 110TRP A 111LEU A 194LEU A 223GLY A 224PHE A 227 | D16 A 402 (-4.0A)NoneNoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A) | 1.10A | 1tsnA-4iqqA:36.1 | 1tsnA-4iqqA:44.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TSN_A_C2FA266_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | ILE A 132LEU A 216GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.0A)NoneD16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 1.08A | 1tsnA-5h3aA:36.3 | 1tsnA-5h3aA:47.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TSN_A_C2FA266_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | ILE A 132TRP A 133LEU A 216GLY A 246PHE A 249 | D16 A 401 ( 4.0A)NoneNoneD16 A 401 ( 3.2A)D16 A 401 (-3.4A) | 1.01A | 1tsnA-5h3aA:36.3 | 1tsnA-5h3aA:47.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2KCE_A_D16A566_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 7 / 12 | GLU A 87TRP A 109LEU A 192ASP A 218GLY A 222TYR A 258ALA A 312 | D16 A 414 (-3.8A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.49A | 2kceA-1hvyA:39.6 | 2kceA-1hvyA:51.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2KCE_A_D16A566_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 7 / 12 | TRP A 109LEU A 192ASP A 218GLY A 222PHE A 225TYR A 258ALA A 312 | D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.83A | 2kceA-1hvyA:39.6 | 2kceA-1hvyA:51.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2KCE_A_D16A566_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | GLU A 111LEU A 216ASP A 242GLY A 246TYR A 282 | D16 A 401 ( 4.7A)NoneD16 A 401 ( 4.0A)D16 A 401 ( 3.2A)UMP A 402 (-4.5A) | 0.77A | 2kceA-5h3aA:36.3 | 2kceA-5h3aA:47.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2KCE_A_D16A566_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | LEU A 216ASP A 242GLY A 246PHE A 249TYR A 282 | NoneD16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 1.28A | 2kceA-5h3aA:36.3 | 2kceA-5h3aA:47.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2KCE_B_D16B568_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 12 | TRP A 109LEU A 192ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258ALA A 312 | D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.57A | 2kceB-1hvyA:39.5 | 2kceB-1hvyA:51.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2KCE_B_D16B568_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | LEU A 216ASP A 242GLY A 246PHE A 249TYR A 282 | NoneD16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 0.85A | 2kceB-5h3aA:36.6 | 2kceB-5h3aA:47.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2TSR_A_D16A309_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 7 | ILE A 108ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.57A | 2tsrA-1hvyA:44.0 | 2tsrA-1hvyA:92.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2TSR_A_D16A309_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 7 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.22A | 2tsrA-4iqqA:43.0 | 2tsrA-4iqqA:63.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2TSR_A_D16A309_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 7 | ILE A 132ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 0.23A | 2tsrA-5h3aA:43.9 | 2tsrA-5h3aA:70.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2TSR_B_D16B409_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 7 / 8 | ILE A 108TRP A 109ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.51A | 2tsrB-1hvyA:44.9 | 2tsrB-1hvyA:92.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2TSR_C_D16C509_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 10 | PHE A 80GLU A 87ILE A 108TRP A 109ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.8A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.60A | 2tsrC-1hvyA:43.8 | 2tsrC-1hvyA:92.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2TSR_C_D16C509_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 7 / 10 | GLU A 89ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | NoneD16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.33A | 2tsrC-4iqqA:42.9 | 2tsrC-4iqqA:63.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2TSR_C_D16C509_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 7 / 10 | PHE A 104GLU A 111ILE A 132ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 (-3.6A)D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 0.30A | 2tsrC-5h3aA:43.9 | 2tsrC-5h3aA:70.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2TSR_C_D16C509_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 10 | PHE A 104GLU A 111ILE A 132TRP A 133PHE A 249 | D16 A 401 (-3.6A)D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)NoneD16 A 401 (-3.4A) | 0.75A | 2tsrC-5h3aA:43.9 | 2tsrC-5h3aA:70.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2TSR_D_D16D609_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 5 / 9 | PHE A 80ILE A 108PHE A 225TYR A 258THR A 306 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A)None | 0.72A | 2tsrD-1hvyA:21.0 | 2tsrD-1hvyA:92.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2TSR_D_D16D609_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 9 | PHE A 80ILE A 108TRP A 109ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.54A | 2tsrD-1hvyA:21.0 | 2tsrD-1hvyA:92.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2TSR_D_D16D609_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 9 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.19A | 2tsrD-4iqqA:12.9 | 2tsrD-4iqqA:63.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2TSR_D_D16D609_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 9 | PHE A 104ILE A 132ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 0.31A | 2tsrD-5h3aA:20.7 | 2tsrD-5h3aA:70.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2TSR_D_D16D609_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 9 | PHE A 104ILE A 132ASP A 242GLY A 246TYR A 282THR A 330 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)UMP A 402 (-4.5A)None | 0.63A | 2tsrD-5h3aA:20.7 | 2tsrD-5h3aA:70.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K2H_A_LYAA513_1 (DIHYDROFOLATEREDUCTASE/THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 12 | GLU A 87ILE A 108TRP A 109LEU A 192ASP A 218LEU A 221GLY A 222TYR A 258MET A 311 | D16 A 414 (-3.8A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A) | 0.66A | 3k2hA-1hvyA:19.4 | 3k2hA-1hvyA:51.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K2H_A_LYAA513_1 (DIHYDROFOLATEREDUCTASE/THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 7 / 12 | ILE A 108TRP A 109LEU A 192GLY A 222PHE A 225TYR A 258MET A 311 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A) | 0.98A | 3k2hA-1hvyA:19.4 | 3k2hA-1hvyA:51.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K2H_A_LYAA513_1 (DIHYDROFOLATEREDUCTASE/THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | GLU A 89ILE A 110LEU A 194LEU A 223GLY A 224 | NoneD16 A 402 (-4.0A)NoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A) | 0.98A | 3k2hA-4iqqA:12.4 | 3k2hA-4iqqA:35.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K2H_A_LYAA513_1 (DIHYDROFOLATEREDUCTASE/THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | GLU A 89ILE A 110LEU A 223GLY A 224TYR A 260 | NoneD16 A 402 (-4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 0.86A | 3k2hA-4iqqA:12.4 | 3k2hA-4iqqA:35.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K2H_A_LYAA513_1 (DIHYDROFOLATEREDUCTASE/THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | GLU A 89ILE A 110TRP A 111LEU A 194LEU A 223 | NoneD16 A 402 (-4.0A)NoneNoneD16 A 402 (-3.7A) | 0.92A | 3k2hA-4iqqA:12.4 | 3k2hA-4iqqA:35.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K2H_A_LYAA513_1 (DIHYDROFOLATEREDUCTASE/THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ILE A 110LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 1.11A | 3k2hA-4iqqA:12.4 | 3k2hA-4iqqA:35.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K2H_A_LYAA513_1 (DIHYDROFOLATEREDUCTASE/THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | GLU A 111ILE A 132LEU A 216GLY A 246TYR A 282 | D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)NoneD16 A 401 ( 3.2A)UMP A 402 (-4.5A) | 0.95A | 3k2hA-5h3aA:19.3 | 3k2hA-5h3aA:32.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K2H_B_LYAB513_1 (DIHYDROFOLATEREDUCTASE/THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 12 | GLU A 87ILE A 108TRP A 109LEU A 192ASP A 218LEU A 221GLY A 222TYR A 258MET A 311 | D16 A 414 (-3.8A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A) | 0.71A | 3k2hB-1hvyA:20.5 | 3k2hB-1hvyA:51.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K2H_B_LYAB513_1 (DIHYDROFOLATEREDUCTASE/THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 12 | ILE A 108TRP A 109LEU A 192ASP A 218GLY A 222PHE A 225TYR A 258MET A 311 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A) | 0.97A | 3k2hB-1hvyA:20.5 | 3k2hB-1hvyA:51.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K2H_B_LYAB513_1 (DIHYDROFOLATEREDUCTASE/THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | GLU A 89ILE A 110LEU A 194LEU A 223GLY A 224 | NoneD16 A 402 (-4.0A)NoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A) | 0.97A | 3k2hB-4iqqA:13.0 | 3k2hB-4iqqA:35.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K2H_B_LYAB513_1 (DIHYDROFOLATEREDUCTASE/THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | GLU A 89ILE A 110LEU A 223GLY A 224TYR A 260 | NoneD16 A 402 (-4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 0.87A | 3k2hB-4iqqA:13.0 | 3k2hB-4iqqA:35.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K2H_B_LYAB513_1 (DIHYDROFOLATEREDUCTASE/THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | GLU A 89ILE A 110TRP A 111LEU A 194LEU A 223 | NoneD16 A 402 (-4.0A)NoneNoneD16 A 402 (-3.7A) | 0.88A | 3k2hB-4iqqA:13.0 | 3k2hB-4iqqA:35.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K2H_B_LYAB513_1 (DIHYDROFOLATEREDUCTASE/THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ILE A 110LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 1.10A | 3k2hB-4iqqA:13.0 | 3k2hB-4iqqA:35.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K2H_B_LYAB513_1 (DIHYDROFOLATEREDUCTASE/THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | GLU A 111ILE A 132LEU A 216GLY A 246TYR A 282 | D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)NoneD16 A 401 ( 3.2A)UMP A 402 (-4.5A) | 0.96A | 3k2hB-5h3aA:20.4 | 3k2hB-5h3aA:32.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K2H_B_LYAB513_1 (DIHYDROFOLATEREDUCTASE/THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | GLU A 111ILE A 132TRP A 133LEU A 216GLY A 246 | D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)NoneNoneD16 A 401 ( 3.2A) | 0.81A | 3k2hB-5h3aA:20.4 | 3k2hB-5h3aA:32.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LMY_A_CP6A562_1 (BETA-HEXOSAMINIDASESUBUNIT BETA) |
5a6b | N-ACETYL-BETA-D-GLUCOSAMINIDASE (Streptococcuspneumoniae) | 5 / 12 | ARG D 94HIS D 169TRP D 306TYR D 308TRP D 373 | OAN D1627 (-2.8A)OAN D1627 ( 4.9A)OAN D1627 (-3.6A)OAN D1627 (-4.3A)OAN D1627 (-3.7A) | 0.67A | 3lmyA-5a6bD:27.3 | 3lmyA-5a6bD:21.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LMY_B_CP6B563_1 (BETA-HEXOSAMINIDASESUBUNIT BETA) |
5a6b | N-ACETYL-BETA-D-GLUCOSAMINIDASE (Streptococcuspneumoniae) | 6 / 12 | ARG D 94HIS D 169TRP D 266TRP D 306TYR D 308TRP D 373 | OAN D1627 (-2.8A)OAN D1627 ( 4.9A)OAN D1627 (-3.6A)OAN D1627 (-3.6A)OAN D1627 (-4.3A)OAN D1627 (-3.7A) | 0.70A | 3lmyB-5a6bD:27.3 | 3lmyB-5a6bD:21.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NRR_A_D16A530_1 (DIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 12 | GLU A 87ILE A 108TRP A 109ASN A 112ASP A 218LEU A 221GLY A 222TYR A 258MET A 311 | D16 A 414 (-3.8A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A) | 0.51A | 3nrrA-1hvyA:19.9 | 3nrrA-1hvyA:51.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NRR_A_D16A530_1 (DIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 12 | ILE A 108TRP A 109ASN A 112ASP A 218GLY A 222PHE A 225TYR A 258MET A 311 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)D16 A 414 ( 3.6A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A) | 0.88A | 3nrrA-1hvyA:19.9 | 3nrrA-1hvyA:51.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NRR_A_D16A530_1 (DIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | GLU A 89ILE A 110ASN A 114LEU A 223GLY A 224 | NoneD16 A 402 (-4.0A)NoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A) | 0.86A | 3nrrA-4iqqA:14.7 | 3nrrA-4iqqA:35.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NRR_A_D16A530_1 (DIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 12 | GLU A 89ILE A 110ASP A 220LEU A 223GLY A 224TYR A 260 | NoneD16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 0.71A | 3nrrA-4iqqA:14.7 | 3nrrA-4iqqA:35.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NRR_A_D16A530_1 (DIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ILE A 110ASN A 114LEU A 223GLY A 224PHE A 227 | D16 A 402 (-4.0A)NoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A) | 1.21A | 3nrrA-4iqqA:14.7 | 3nrrA-4iqqA:35.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NRR_A_D16A530_1 (DIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 12 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 1.01A | 3nrrA-4iqqA:14.7 | 3nrrA-4iqqA:35.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NRR_A_D16A530_1 (DIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | GLU A 111ILE A 132ASP A 242GLY A 246TYR A 282 | D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)UMP A 402 (-4.5A) | 0.65A | 3nrrA-5h3aA:undetectable | 3nrrA-5h3aA:30.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NRR_B_D16B530_1 (DIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 12 | GLU A 87ILE A 108TRP A 109ASN A 112ASP A 218LEU A 221GLY A 222TYR A 258MET A 311 | D16 A 414 (-3.8A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A) | 0.50A | 3nrrB-1hvyA:20.0 | 3nrrB-1hvyA:51.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NRR_B_D16B530_1 (DIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 12 | ILE A 108TRP A 109ASN A 112ASP A 218GLY A 222PHE A 225TYR A 258MET A 311 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)D16 A 414 ( 3.6A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A) | 0.88A | 3nrrB-1hvyA:20.0 | 3nrrB-1hvyA:51.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NRR_B_D16B530_1 (DIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | GLU A 89ILE A 110ASN A 114LEU A 223GLY A 224 | NoneD16 A 402 (-4.0A)NoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A) | 0.84A | 3nrrB-4iqqA:14.8 | 3nrrB-4iqqA:35.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NRR_B_D16B530_1 (DIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 12 | GLU A 89ILE A 110ASP A 220LEU A 223GLY A 224TYR A 260 | NoneD16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 0.70A | 3nrrB-4iqqA:14.8 | 3nrrB-4iqqA:35.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NRR_B_D16B530_1 (DIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ILE A 110ASN A 114LEU A 223GLY A 224PHE A 227 | D16 A 402 (-4.0A)NoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A) | 1.21A | 3nrrB-4iqqA:14.8 | 3nrrB-4iqqA:35.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NRR_B_D16B530_1 (DIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 12 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 1.02A | 3nrrB-4iqqA:14.8 | 3nrrB-4iqqA:35.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NRR_B_D16B530_1 (DIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | GLU A 111ILE A 132ASN A 136GLY A 246TYR A 282 | D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)NoneD16 A 401 ( 3.2A)UMP A 402 (-4.5A) | 0.88A | 3nrrB-5h3aA:undetectable | 3nrrB-5h3aA:30.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NRR_B_D16B530_1 (DIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | GLU A 111ILE A 132ASP A 242GLY A 246TYR A 282 | D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)UMP A 402 (-4.5A) | 0.64A | 3nrrB-5h3aA:undetectable | 3nrrB-5h3aA:30.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UWL_B_FOZB316_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 12 | ILE A 108LEU A 192GLY A 222PHE A 225ASN A 226TYR A 258 | D16 A 414 (-3.7A)NoneD16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 (-3.0A)UMP A 314 ( 4.4A) | 1.08A | 3uwlB-1hvyA:39.5 | 3uwlB-1hvyA:48.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UWL_B_FOZB316_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 7 / 12 | ILE A 108LEU A 192LEU A 221GLY A 222ASN A 226TYR A 258ALA A 312 | D16 A 414 (-3.7A)NoneD16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 (-3.0A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.89A | 3uwlB-1hvyA:39.5 | 3uwlB-1hvyA:48.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UWL_B_FOZB316_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 7 / 12 | ILE A 108TRP A 109LEU A 192GLY A 222ASN A 226TYR A 258ALA A 312 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 (-3.3A)UMP A 314 (-3.0A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.82A | 3uwlB-1hvyA:39.5 | 3uwlB-1hvyA:48.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UWL_B_FOZB316_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 12 | ILE A 108TRP A 109LEU A 192HIS A 196TYR A 258ALA A 312 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneUMP A 314 (-3.9A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 1.09A | 3uwlB-1hvyA:39.5 | 3uwlB-1hvyA:48.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UWL_B_FOZB316_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 12 | ILE A 110HIS A 198LEU A 223GLY A 224ASN A 228TYR A 260 | D16 A 402 (-4.0A)UMP A 401 ( 4.7A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)UMP A 401 (-3.3A)D16 A 402 ( 4.2A) | 0.74A | 3uwlB-4iqqA:35.8 | 3uwlB-4iqqA:43.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UWL_B_FOZB316_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 12 | ILE A 110LEU A 223GLY A 224PHE A 227ASN A 228TYR A 260 | D16 A 402 (-4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)UMP A 401 (-3.3A)D16 A 402 ( 4.2A) | 1.07A | 3uwlB-4iqqA:35.8 | 3uwlB-4iqqA:43.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UWL_B_FOZB316_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 7 / 12 | ILE A 110TRP A 111LEU A 194HIS A 198LEU A 223GLY A 224ASN A 228 | D16 A 402 (-4.0A)NoneNoneUMP A 401 ( 4.7A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)UMP A 401 (-3.3A) | 0.77A | 3uwlB-4iqqA:35.8 | 3uwlB-4iqqA:43.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UWL_D_FOZD316_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 12 | LEU A 192LEU A 221GLY A 222ASN A 226TYR A 258ALA A 312 | NoneD16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 (-3.0A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.95A | 3uwlD-1hvyA:38.7 | 3uwlD-1hvyA:48.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UWL_D_FOZD316_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 12 | LEU A 192LEU A 221GLY A 222PHE A 225ASN A 226TYR A 258 | NoneD16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 (-3.0A)UMP A 314 ( 4.4A) | 1.15A | 3uwlD-1hvyA:38.7 | 3uwlD-1hvyA:48.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UWL_D_FOZD316_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 12 | TRP A 109LEU A 192GLY A 222ASN A 226TYR A 258ALA A 312 | D16 A 414 (-3.7A)NoneD16 A 414 (-3.3A)UMP A 314 (-3.0A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.82A | 3uwlD-1hvyA:38.7 | 3uwlD-1hvyA:48.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UWL_D_FOZD316_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | HIS A 198LEU A 223GLY A 224ASN A 228TYR A 260 | UMP A 401 ( 4.7A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)UMP A 401 (-3.3A)D16 A 402 ( 4.2A) | 0.83A | 3uwlD-4iqqA:35.0 | 3uwlD-4iqqA:43.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UWL_D_FOZD316_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 12 | TRP A 111LEU A 194HIS A 198LEU A 223GLY A 224ASN A 228 | NoneNoneUMP A 401 ( 4.7A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)UMP A 401 (-3.3A) | 0.78A | 3uwlD-4iqqA:35.0 | 3uwlD-4iqqA:43.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UWL_D_FOZD316_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | LEU A 216HIS A 220GLY A 246ASN A 250TYR A 282 | NoneUMP A 402 (-3.9A)D16 A 401 ( 3.2A)UMP A 402 (-3.2A)UMP A 402 (-4.5A) | 0.83A | 3uwlD-5h3aA:34.8 | 3uwlD-5h3aA:45.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UWL_D_FOZD316_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | TRP A 133LEU A 216HIS A 220GLY A 246ASN A 250 | NoneNoneUMP A 402 (-3.9A)D16 A 401 ( 3.2A)UMP A 402 (-3.2A) | 0.84A | 3uwlD-5h3aA:34.8 | 3uwlD-5h3aA:45.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EB4_A_D16A402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 12 / 12 | PHE A 80ILE A 108TRP A 109ASP A 218LEU A 221GLY A 222PHE A 225ASN A 226TYR A 258LYS A 308MET A 311ALA A 312 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 (-3.0A)UMP A 314 ( 4.4A)NoneD16 A 414 (-3.4A)D16 A 414 (-3.6A) | 0.59A | 4eb4A-1hvyA:47.8 | 4eb4A-1hvyA:93.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EB4_A_D16A402_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 7 / 12 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227ASN A 228TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)UMP A 401 (-3.3A)D16 A 402 ( 4.2A) | 0.42A | 4eb4A-4iqqA:41.6 | 4eb4A-4iqqA:62.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EB4_A_D16A402_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 7 / 12 | PHE A 104ILE A 132ASP A 242GLY A 246PHE A 249ASN A 250TYR A 282 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-3.2A)UMP A 402 (-4.5A) | 0.40A | 4eb4A-5h3aA:42.5 | 4eb4A-5h3aA:71.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EB4_B_D16B402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 11 / 12 | PHE A 80ILE A 108ASP A 218LEU A 221GLY A 222PHE A 225ASN A 226TYR A 258LYS A 308MET A 311ALA A 312 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 (-3.0A)UMP A 314 ( 4.4A)NoneD16 A 414 (-3.4A)D16 A 414 (-3.6A) | 0.62A | 4eb4B-1hvyA:47.7 | 4eb4B-1hvyA:93.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EB4_B_D16B402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 11 / 12 | PHE A 80ILE A 108TRP A 109ASP A 218LEU A 221GLY A 222PHE A 225ASN A 226TYR A 258MET A 311ALA A 312 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 (-3.0A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A)D16 A 414 (-3.6A) | 0.48A | 4eb4B-1hvyA:47.7 | 4eb4B-1hvyA:93.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EB4_B_D16B402_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 7 / 12 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227ASN A 228TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)UMP A 401 (-3.3A)D16 A 402 ( 4.2A) | 0.46A | 4eb4B-4iqqA:41.7 | 4eb4B-4iqqA:62.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EB4_B_D16B402_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 7 / 12 | PHE A 104ILE A 132ASP A 242GLY A 246PHE A 249ASN A 250TYR A 282 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-3.2A)UMP A 402 (-4.5A) | 0.45A | 4eb4B-5h3aA:42.2 | 4eb4B-5h3aA:71.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EB4_C_D16C402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 9 | PHE A 80ILE A 108ASP A 218LEU A 221GLY A 222PHE A 225ASN A 226TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 (-3.0A)UMP A 314 ( 4.4A) | 0.48A | 4eb4C-1hvyA:44.0 | 4eb4C-1hvyA:93.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EB4_C_D16C402_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 7 / 9 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227ASN A 228TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)UMP A 401 (-3.3A)D16 A 402 ( 4.2A) | 0.26A | 4eb4C-4iqqA:42.6 | 4eb4C-4iqqA:62.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EB4_C_D16C402_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 7 / 9 | PHE A 104ILE A 132ASP A 242GLY A 246PHE A 249ASN A 250TYR A 282 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-3.2A)UMP A 402 (-4.5A) | 0.22A | 4eb4C-5h3aA:43.2 | 4eb4C-5h3aA:71.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EB4_D_D16D402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 10 / 10 | PHE A 80ILE A 108TRP A 109ASP A 218LEU A 221GLY A 222PHE A 225ASN A 226TYR A 258LYS A 308 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 (-3.0A)UMP A 314 ( 4.4A)None | 0.84A | 4eb4D-1hvyA:45.6 | 4eb4D-1hvyA:93.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EB4_D_D16D402_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 7 / 10 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227ASN A 228TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)UMP A 401 (-3.3A)D16 A 402 ( 4.2A) | 0.23A | 4eb4D-4iqqA:42.8 | 4eb4D-4iqqA:62.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EB4_D_D16D402_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 7 / 10 | PHE A 104ILE A 132ASP A 242GLY A 246PHE A 249ASN A 250TYR A 282 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-3.2A)UMP A 402 (-4.5A) | 0.25A | 4eb4D-5h3aA:43.1 | 4eb4D-5h3aA:71.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EB4_D_D16D402_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 10 | PHE A 104ILE A 132TRP A 133PHE A 249ASN A 250TYR A 282 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)NoneD16 A 401 (-3.4A)UMP A 402 (-3.2A)UMP A 402 (-4.5A) | 0.71A | 4eb4D-5h3aA:43.1 | 4eb4D-5h3aA:71.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOG_A_C2FA302_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 7 / 11 | ILE A 108TRP A 109LEU A 192ASP A 218GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.79A | 4fogA-1hvyA:38.0 | 4fogA-1hvyA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOG_A_C2FA302_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 7 / 11 | LYS A 77ILE A 108TRP A 109LEU A 192ASP A 218GLY A 222TYR A 258 | D16 A 414 ( 4.3A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A) | 0.47A | 4fogA-1hvyA:38.0 | 4fogA-1hvyA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOG_A_C2FA302_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 11 | ILE A 110LEU A 194GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)NoneD16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 1.16A | 4fogA-4iqqA:36.2 | 4fogA-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOG_A_C2FA302_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 11 | ILE A 110TRP A 111LEU A 194GLY A 224PHE A 227 | D16 A 402 (-4.0A)NoneNoneD16 A 402 ( 3.1A)D16 A 402 (-3.2A) | 1.08A | 4fogA-4iqqA:36.2 | 4fogA-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOG_A_C2FA302_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 11 | LYS A 79ILE A 110LEU A 194GLY A 224TYR A 260 | D16 A 402 ( 4.5A)D16 A 402 (-4.0A)NoneD16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 1.15A | 4fogA-4iqqA:36.2 | 4fogA-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOG_A_C2FA302_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 11 | LYS A 79ILE A 110TRP A 111LEU A 194GLY A 224 | D16 A 402 ( 4.5A)D16 A 402 (-4.0A)NoneNoneD16 A 402 ( 3.1A) | 1.03A | 4fogA-4iqqA:36.2 | 4fogA-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOG_A_C2FA302_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 11 | ILE A 132LEU A 216ASP A 242GLY A 246TYR A 282 | D16 A 401 ( 4.0A)NoneD16 A 401 ( 4.0A)D16 A 401 ( 3.2A)UMP A 402 (-4.5A) | 0.77A | 4fogA-5h3aA:35.9 | 4fogA-5h3aA:49.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOG_A_C2FA302_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 11 | ILE A 132TRP A 133LEU A 216GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.0A)NoneNoneD16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 1.04A | 4fogA-5h3aA:35.9 | 4fogA-5h3aA:49.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOG_C_C2FC302_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 11 | ILE A 108LEU A 192ASP A 218GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.93A | 4fogC-1hvyA:38.7 | 4fogC-1hvyA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOG_C_C2FC302_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 11 | ILE A 108TRP A 109LEU A 192ASP A 218GLY A 222TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A) | 0.61A | 4fogC-1hvyA:38.7 | 4fogC-1hvyA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOG_C_C2FC302_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 11 | ILE A 132TRP A 133GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.0A)NoneD16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 1.10A | 4fogC-5h3aA:35.9 | 4fogC-5h3aA:49.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOG_C_C2FC302_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 11 | ILE A 132TRP A 133LEU A 216GLY A 246TYR A 282 | D16 A 401 ( 4.0A)NoneNoneD16 A 401 ( 3.2A)UMP A 402 (-4.5A) | 0.70A | 4fogC-5h3aA:35.9 | 4fogC-5h3aA:49.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOG_D_C2FD302_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 11 | ILE A 108LEU A 192ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258ALA A 312 | D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.86A | 4fogD-1hvyA:39.4 | 4fogD-1hvyA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOG_D_C2FD302_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 11 | LYS A 77ILE A 108LEU A 192ASP A 218LEU A 221GLY A 222TYR A 258ALA A 312 | D16 A 414 ( 4.3A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.65A | 4fogD-1hvyA:39.4 | 4fogD-1hvyA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOG_D_C2FD302_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 11 | LYS A 77ILE A 108TRP A 109LEU A 192ASP A 218GLY A 222TYR A 258ALA A 312 | D16 A 414 ( 4.3A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.57A | 4fogD-1hvyA:39.4 | 4fogD-1hvyA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOG_D_C2FD302_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 11 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.95A | 4fogD-4iqqA:36.0 | 4fogD-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOG_D_C2FD302_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 11 | ILE A 110TRP A 111LEU A 223GLY A 224PHE A 227 | D16 A 402 (-4.0A)NoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A) | 1.06A | 4fogD-4iqqA:36.0 | 4fogD-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOG_D_C2FD302_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 11 | ILE A 132LEU A 216ASP A 242GLY A 246TYR A 282 | D16 A 401 ( 4.0A)NoneD16 A 401 ( 4.0A)D16 A 401 ( 3.2A)UMP A 402 (-4.5A) | 0.88A | 4fogD-5h3aA:36.0 | 4fogD-5h3aA:49.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOG_D_C2FD302_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 11 | ILE A 132TRP A 133GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.0A)NoneD16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 1.03A | 4fogD-5h3aA:36.0 | 4fogD-5h3aA:49.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOG_D_C2FD302_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 11 | ILE A 132TRP A 133LEU A 216GLY A 246TYR A 282 | D16 A 401 ( 4.0A)NoneNoneD16 A 401 ( 3.2A)UMP A 402 (-4.5A) | 0.81A | 4fogD-5h3aA:36.0 | 4fogD-5h3aA:49.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_A_D16A301_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 12 | GLU A 87ILE A 108TRP A 109LEU A 192ASP A 218LEU A 221GLY A 222TYR A 258 | D16 A 414 (-3.8A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A) | 0.31A | 4foxA-1hvyA:38.6 | 4foxA-1hvyA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_A_D16A301_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 12 | ILE A 108TRP A 109LEU A 192ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.73A | 4foxA-1hvyA:38.6 | 4foxA-1hvyA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_A_D16A301_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 12 | GLU A 89ILE A 110ASP A 220LEU A 223GLY A 224TYR A 260 | NoneD16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 0.70A | 4foxA-4iqqA:36.2 | 4foxA-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_A_D16A301_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | GLU A 89ILE A 110LEU A 194LEU A 223GLY A 224 | NoneD16 A 402 (-4.0A)NoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A) | 0.80A | 4foxA-4iqqA:36.2 | 4foxA-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_A_D16A301_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | GLU A 89ILE A 110TRP A 111LEU A 194LEU A 223 | NoneD16 A 402 (-4.0A)NoneNoneD16 A 402 (-3.7A) | 0.90A | 4foxA-4iqqA:36.2 | 4foxA-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_A_D16A301_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 12 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.95A | 4foxA-4iqqA:36.2 | 4foxA-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_A_D16A301_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 12 | GLU A 111ILE A 132LEU A 216ASP A 242GLY A 246TYR A 282 | D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)NoneD16 A 401 ( 4.0A)D16 A 401 ( 3.2A)UMP A 402 (-4.5A) | 0.78A | 4foxA-5h3aA:36.1 | 4foxA-5h3aA:49.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_A_D16A301_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 12 | ILE A 132LEU A 216ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.0A)NoneD16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 1.18A | 4foxA-5h3aA:36.1 | 4foxA-5h3aA:49.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_B_D16B302_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 12 | GLU A 87ILE A 108TRP A 109LEU A 192ASP A 218LEU A 221GLY A 222TYR A 258 | D16 A 414 (-3.8A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A) | 0.25A | 4foxB-1hvyA:38.6 | 4foxB-1hvyA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_B_D16B302_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 7 / 12 | ILE A 108TRP A 109LEU A 192ASP A 218GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.82A | 4foxB-1hvyA:38.6 | 4foxB-1hvyA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_B_D16B302_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 12 | GLU A 89ILE A 110ASP A 220LEU A 223GLY A 224TYR A 260 | NoneD16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 0.66A | 4foxB-4iqqA:36.3 | 4foxB-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_B_D16B302_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | GLU A 89ILE A 110LEU A 194LEU A 223GLY A 224 | NoneD16 A 402 (-4.0A)NoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A) | 0.80A | 4foxB-4iqqA:36.3 | 4foxB-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_B_D16B302_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ILE A 110LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 1.04A | 4foxB-4iqqA:36.3 | 4foxB-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_B_D16B302_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 12 | GLU A 111ILE A 132LEU A 216ASP A 242GLY A 246TYR A 282 | D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)NoneD16 A 401 ( 4.0A)D16 A 401 ( 3.2A)UMP A 402 (-4.5A) | 0.75A | 4foxB-5h3aA:36.3 | 4foxB-5h3aA:49.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_B_D16B302_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | GLU A 111ILE A 132TRP A 133LEU A 216TYR A 282 | D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)NoneNoneUMP A 402 (-4.5A) | 0.75A | 4foxB-5h3aA:36.3 | 4foxB-5h3aA:49.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_B_D16B302_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | ILE A 132TRP A 133LEU A 216PHE A 249TYR A 282 | D16 A 401 ( 4.0A)NoneNoneD16 A 401 (-3.4A)UMP A 402 (-4.5A) | 1.20A | 4foxB-5h3aA:36.3 | 4foxB-5h3aA:49.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_C_D16C301_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 7 / 11 | GLU A 87TRP A 109LEU A 192ASP A 218LEU A 221GLY A 222TYR A 258 | D16 A 414 (-3.8A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A) | 0.32A | 4foxC-1hvyA:38.3 | 4foxC-1hvyA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_C_D16C301_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 7 / 11 | TRP A 109LEU A 192ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.79A | 4foxC-1hvyA:38.3 | 4foxC-1hvyA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_C_D16C301_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 11 | GLU A 89ASP A 220LEU A 223GLY A 224TYR A 260 | NoneD16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 0.70A | 4foxC-4iqqA:36.1 | 4foxC-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_C_D16C301_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 11 | GLU A 111LEU A 216ASP A 242GLY A 246TYR A 282 | D16 A 401 ( 4.7A)NoneD16 A 401 ( 4.0A)D16 A 401 ( 3.2A)UMP A 402 (-4.5A) | 0.82A | 4foxC-5h3aA:36.1 | 4foxC-5h3aA:49.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_D_D16D301_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 12 | GLU A 87ILE A 108TRP A 109ASP A 218LEU A 221GLY A 222TYR A 258ALA A 312 | D16 A 414 (-3.8A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.56A | 4foxD-1hvyA:39.6 | 4foxD-1hvyA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_D_D16D301_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 12 | ILE A 108TRP A 109ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258ALA A 312 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.80A | 4foxD-1hvyA:39.6 | 4foxD-1hvyA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_D_D16D301_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | GLU A 89ILE A 110LEU A 223GLY A 224TYR A 260 | NoneD16 A 402 (-4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 0.74A | 4foxD-4iqqA:35.9 | 4foxD-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_D_D16D301_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 12 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.94A | 4foxD-4iqqA:35.9 | 4foxD-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_D_D16D301_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | GLU A 111ILE A 132ASP A 242GLY A 246TYR A 282 | D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)UMP A 402 (-4.5A) | 0.63A | 4foxD-5h3aA:35.8 | 4foxD-5h3aA:49.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_E_D16E301_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 12 | ILE A 108TRP A 109ASP A 218GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.80A | 4foxE-1hvyA:38.6 | 4foxE-1hvyA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_E_D16E301_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 12 | LYS A 77GLU A 87ILE A 108TRP A 109ASP A 218LEU A 221GLY A 222TYR A 258 | D16 A 414 ( 4.3A)D16 A 414 (-3.8A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A) | 0.28A | 4foxE-1hvyA:38.6 | 4foxE-1hvyA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_E_D16E301_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | GLU A 89ILE A 110LEU A 223GLY A 224TYR A 260 | NoneD16 A 402 (-4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 0.61A | 4foxE-4iqqA:36.5 | 4foxE-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_E_D16E301_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ILE A 110ASP A 220LEU A 223GLY A 224TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 0.62A | 4foxE-4iqqA:36.5 | 4foxE-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_E_D16E301_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ILE A 110LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.99A | 4foxE-4iqqA:36.5 | 4foxE-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_E_D16E301_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | LYS A 79GLU A 89ILE A 110GLY A 224TYR A 260 | D16 A 402 ( 4.5A)NoneD16 A 402 (-4.0A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 1.00A | 4foxE-4iqqA:36.5 | 4foxE-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_E_D16E301_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | GLU A 111ILE A 132ASP A 242GLY A 246TYR A 282 | D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)UMP A 402 (-4.5A) | 0.64A | 4foxE-5h3aA:36.2 | 4foxE-5h3aA:49.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_E_D16E301_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | GLU A 111ILE A 132TRP A 133GLY A 246TYR A 282 | D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)NoneD16 A 401 ( 3.2A)UMP A 402 (-4.5A) | 0.69A | 4foxE-5h3aA:36.2 | 4foxE-5h3aA:49.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_E_D16E301_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | ILE A 132TRP A 133GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.0A)NoneD16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 1.20A | 4foxE-5h3aA:36.2 | 4foxE-5h3aA:49.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_F_D16F301_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 7 / 11 | GLU A 87ILE A 108TRP A 109LEU A 192ASP A 218GLY A 222TYR A 258 | D16 A 414 (-3.8A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A) | 0.33A | 4foxF-1hvyA:38.5 | 4foxF-1hvyA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_F_D16F301_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 7 / 11 | ILE A 108TRP A 109LEU A 192ASP A 218GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.75A | 4foxF-1hvyA:38.5 | 4foxF-1hvyA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_F_D16F301_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 11 | GLU A 89ILE A 110ASP A 220GLY A 224TYR A 260 | NoneD16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 0.71A | 4foxF-4iqqA:36.1 | 4foxF-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_F_D16F301_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 11 | GLU A 111ILE A 132LEU A 216ASP A 242GLY A 246TYR A 282 | D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)NoneD16 A 401 ( 4.0A)D16 A 401 ( 3.2A)UMP A 402 (-4.5A) | 0.90A | 4foxF-5h3aA:36.0 | 4foxF-5h3aA:49.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_F_D16F301_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 11 | ILE A 132LEU A 216GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.0A)NoneD16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 1.25A | 4foxF-5h3aA:36.0 | 4foxF-5h3aA:49.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_G_D16G301_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 12 | GLU A 87ILE A 108TRP A 109LEU A 192ASP A 218LEU A 221GLY A 222TYR A 258 | D16 A 414 (-3.8A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A) | 0.33A | 4foxG-1hvyA:38.4 | 4foxG-1hvyA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_G_D16G301_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 12 | ILE A 108TRP A 109LEU A 192ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.78A | 4foxG-1hvyA:38.4 | 4foxG-1hvyA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_G_D16G301_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 12 | GLU A 89ILE A 110ASP A 220LEU A 223GLY A 224TYR A 260 | NoneD16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 0.74A | 4foxG-4iqqA:36.3 | 4foxG-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_G_D16G301_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | GLU A 89ILE A 110LEU A 194LEU A 223GLY A 224 | NoneD16 A 402 (-4.0A)NoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A) | 0.86A | 4foxG-4iqqA:36.3 | 4foxG-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_G_D16G301_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | GLU A 89ILE A 110TRP A 111LEU A 194LEU A 223 | NoneD16 A 402 (-4.0A)NoneNoneD16 A 402 (-3.7A) | 0.89A | 4foxG-4iqqA:36.3 | 4foxG-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_G_D16G301_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 12 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 1.00A | 4foxG-4iqqA:36.3 | 4foxG-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_G_D16G301_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 12 | GLU A 111ILE A 132LEU A 216ASP A 242GLY A 246TYR A 282 | D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)NoneD16 A 401 ( 4.0A)D16 A 401 ( 3.2A)UMP A 402 (-4.5A) | 0.78A | 4foxG-5h3aA:36.0 | 4foxG-5h3aA:49.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_G_D16G301_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | ILE A 132LEU A 216GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.0A)NoneD16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 1.23A | 4foxG-5h3aA:36.0 | 4foxG-5h3aA:49.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_H_D16H301_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 11 | GLU A 87ILE A 108TRP A 109ASP A 218GLY A 222TYR A 258 | D16 A 414 (-3.8A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A) | 0.35A | 4foxH-1hvyA:38.1 | 4foxH-1hvyA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_H_D16H301_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 11 | ILE A 108TRP A 109ASP A 218GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.68A | 4foxH-1hvyA:38.1 | 4foxH-1hvyA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_H_D16H301_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 11 | ILE A 110ASP A 220GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.94A | 4foxH-4iqqA:36.0 | 4foxH-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_H_D16H301_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 11 | GLU A 111ILE A 132ASP A 242GLY A 246TYR A 282 | D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)UMP A 402 (-4.5A) | 0.74A | 4foxH-5h3aA:35.7 | 4foxH-5h3aA:49.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_H_D16H301_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 11 | ILE A 132ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 1.02A | 4foxH-5h3aA:35.7 | 4foxH-5h3aA:49.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FQS_A_LYAA302_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 12 | GLU A 87ILE A 108TRP A 109ASP A 218LEU A 221GLY A 222TYR A 258ALA A 312 | D16 A 414 (-3.8A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.63A | 4fqsA-1hvyA:39.4 | 4fqsA-1hvyA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FQS_A_LYAA302_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 12 | ILE A 108TRP A 109ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258ALA A 312 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.88A | 4fqsA-1hvyA:39.4 | 4fqsA-1hvyA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FQS_A_LYAA302_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | GLU A 89ILE A 110LEU A 223GLY A 224TYR A 260 | NoneD16 A 402 (-4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 0.82A | 4fqsA-4iqqA:35.9 | 4fqsA-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FQS_A_LYAA302_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ILE A 110ASP A 220LEU A 223GLY A 224TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 0.85A | 4fqsA-4iqqA:35.9 | 4fqsA-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FQS_A_LYAA302_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ILE A 110LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 1.05A | 4fqsA-4iqqA:35.9 | 4fqsA-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FQS_B_LYAB302_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 12 | GLU A 87ILE A 108TRP A 109ASP A 218LEU A 221GLY A 222TYR A 258ALA A 312 | D16 A 414 (-3.8A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.65A | 4fqsB-1hvyA:39.3 | 4fqsB-1hvyA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FQS_B_LYAB302_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 7 / 12 | ILE A 108TRP A 109LEU A 221GLY A 222PHE A 225TYR A 258ALA A 312 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.93A | 4fqsB-1hvyA:39.3 | 4fqsB-1hvyA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FQS_B_LYAB302_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | GLU A 89ILE A 110LEU A 223GLY A 224TYR A 260 | NoneD16 A 402 (-4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 0.84A | 4fqsB-4iqqA:35.8 | 4fqsB-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FQS_B_LYAB302_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | GLU A 89ILE A 110TRP A 111LEU A 223GLY A 224 | NoneD16 A 402 (-4.0A)NoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A) | 0.85A | 4fqsB-4iqqA:35.8 | 4fqsB-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FQS_B_LYAB302_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ILE A 110ASP A 220LEU A 223GLY A 224TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 0.87A | 4fqsB-4iqqA:35.8 | 4fqsB-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FQS_B_LYAB302_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ILE A 110LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 1.06A | 4fqsB-4iqqA:35.8 | 4fqsB-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FQS_B_LYAB302_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ILE A 110TRP A 111LEU A 223GLY A 224PHE A 227 | D16 A 402 (-4.0A)NoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A) | 1.22A | 4fqsB-4iqqA:35.8 | 4fqsB-4iqqA:43.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IQQ_A_D16A402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 7 | ILE A 108ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.57A | 4iqqA-1hvyA:42.1 | 4iqqA-1hvyA:62.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IQQ_B_D16B402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 5 / 7 | ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258 | D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.55A | 4iqqB-1hvyA:41.2 | 4iqqB-1hvyA:62.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IQQ_B_D16B402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 4 / 7 | ILE A 108LEU A 221GLY A 222PHE A 225 | D16 A 414 (-3.7A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A) | 0.60A | 4iqqB-1hvyA:41.2 | 4iqqB-1hvyA:62.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IQQ_B_D16B402_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 7 | ILE A 132ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 0.34A | 4iqqB-5h3aA:41.5 | 4iqqB-5h3aA:58.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IQQ_C_D16C402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 5 / 7 | ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258 | D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.55A | 4iqqC-1hvyA:41.4 | 4iqqC-1hvyA:62.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IQQ_C_D16C402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 5 / 7 | ILE A 108ASP A 218LEU A 221GLY A 222PHE A 225 | D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A) | 0.61A | 4iqqC-1hvyA:41.4 | 4iqqC-1hvyA:62.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IQQ_C_D16C402_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 7 | ILE A 132ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 0.36A | 4iqqC-5h3aA:42.1 | 4iqqC-5h3aA:58.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IQQ_D_D16D402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 8 | ILE A 108ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.59A | 4iqqD-1hvyA:40.8 | 4iqqD-1hvyA:62.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IQQ_D_D16D402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 5 / 8 | LYS A 77ILE A 108GLY A 222PHE A 225TYR A 258 | D16 A 414 ( 4.3A)D16 A 414 (-3.7A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 1.07A | 4iqqD-1hvyA:40.8 | 4iqqD-1hvyA:62.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5FCT_A_C2FA402_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 11 | PHE A 80ILE A 108TRP A 109ASN A 112LEU A 192ASP A 218GLY A 222TYR A 258MET A 311 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)NoneD16 A 414 ( 3.6A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A) | 0.71A | 5fctA-1hvyA:48.1 | 5fctA-1hvyA:93.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5FCT_A_C2FA402_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 11 | PHE A 80ILE A 108TRP A 109ASN A 112LEU A 192ASP A 218LEU A 221GLY A 222TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A) | 0.58A | 5fctA-1hvyA:48.1 | 5fctA-1hvyA:93.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5FCT_A_C2FA402_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 11 | PHE A 80ILE A 108TRP A 109LEU A 192ASP A 218GLY A 222TYR A 258MET A 311ALA A 312 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A)D16 A 414 (-3.6A) | 0.66A | 5fctA-1hvyA:48.1 | 5fctA-1hvyA:93.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5FCT_A_C2FA402_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 11 | PHE A 80ILE A 108TRP A 109LEU A 192ASP A 218LEU A 221GLY A 222TYR A 258ALA A 312 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.58A | 5fctA-1hvyA:48.1 | 5fctA-1hvyA:93.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5FCT_A_C2FA402_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 11 | PHE A 104ILE A 132LEU A 216GLY A 246TYR A 282 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)NoneD16 A 401 ( 3.2A)UMP A 402 (-4.5A) | 0.99A | 5fctA-5h3aA:42.8 | 5fctA-5h3aA:71.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5FCT_A_C2FA402_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 11 | PHE A 104LEU A 216ASP A 242GLY A 246TYR A 282 | D16 A 401 (-3.6A)NoneD16 A 401 ( 4.0A)D16 A 401 ( 3.2A)UMP A 402 (-4.5A) | 0.98A | 5fctA-5h3aA:42.8 | 5fctA-5h3aA:71.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5FCT_B_C2FB402_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 12 / 12 | LYS A 77VAL A 79PHE A 80ILE A 108TRP A 109LEU A 192CYH A 195LEU A 221TYR A 258MET A 309MET A 311ALA A 312 | D16 A 414 ( 4.3A)NoneD16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneUMP A 314 (-1.8A)D16 A 414 (-4.0A)UMP A 314 ( 4.4A)NoneD16 A 414 (-3.4A)D16 A 414 (-3.6A) | 0.61A | 5fctB-1hvyA:48.2 | 5fctB-1hvyA:93.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5FCT_B_C2FB402_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | LYS A 79ILE A 110CYH A 197LEU A 223TYR A 260 | D16 A 402 ( 4.5A)D16 A 402 (-4.0A)UMP A 401 (-3.3A)D16 A 402 (-3.7A)D16 A 402 ( 4.2A) | 1.18A | 5fctB-4iqqA:42.3 | 5fctB-4iqqA:62.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5FCT_B_C2FB402_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | VAL A 81ILE A 110CYH A 197LEU A 223TYR A 260 | NoneD16 A 402 (-4.0A)UMP A 401 (-3.3A)D16 A 402 (-3.7A)D16 A 402 ( 4.2A) | 0.84A | 5fctB-4iqqA:42.3 | 5fctB-4iqqA:62.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5FCT_B_C2FB402_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | VAL A 81ILE A 110TRP A 111LEU A 194LEU A 223 | NoneD16 A 402 (-4.0A)NoneNoneD16 A 402 (-3.7A) | 0.92A | 5fctB-4iqqA:42.3 | 5fctB-4iqqA:62.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5FCT_B_C2FB402_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | VAL A 103PHE A 104ILE A 132CYH A 219TYR A 282 | NoneD16 A 401 (-3.6A)D16 A 401 ( 4.0A)UMP A 402 (-3.4A)UMP A 402 (-4.5A) | 0.73A | 5fctB-5h3aA:43.0 | 5fctB-5h3aA:71.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5FCT_B_C2FB402_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | VAL A 103PHE A 104ILE A 132LEU A 216TYR A 282 | NoneD16 A 401 (-3.6A)D16 A 401 ( 4.0A)NoneUMP A 402 (-4.5A) | 0.83A | 5fctB-5h3aA:43.0 | 5fctB-5h3aA:71.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5FCT_B_C2FB402_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | VAL A 103PHE A 104ILE A 132TRP A 133LEU A 216 | NoneD16 A 401 (-3.6A)D16 A 401 ( 4.0A)NoneNone | 0.70A | 5fctB-5h3aA:43.0 | 5fctB-5h3aA:71.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5FCT_B_C2FB402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 3 / 3 | ASN A 112ASP A 218GLY A 222 | D16 A 414 ( 4.0A)D16 A 414 ( 3.6A)D16 A 414 (-3.3A) | 0.44A | 5fctB-1hvyA:48.2 | 5fctB-1hvyA:93.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5H3A_A_D16A401_1 (ORF70) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 7 | PHE A 80ILE A 108ASP A 218GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.56A | 5h3aA-1hvyA:43.2 | 5h3aA-1hvyA:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5H3A_A_D16A401_1 (ORF70) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 7 | ILE A 110ASP A 220GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.19A | 5h3aA-4iqqA:42.4 | 5h3aA-4iqqA:58.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5H3A_B_D16B401_1 (ORF70) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 7 | ILE A 108ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.64A | 5h3aB-1hvyA:43.8 | 5h3aB-1hvyA:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5H3A_B_D16B401_1 (ORF70) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 7 | PHE A 80ILE A 108ASP A 218GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.53A | 5h3aB-1hvyA:43.8 | 5h3aB-1hvyA:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5H3A_B_D16B401_1 (ORF70) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 7 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.26A | 5h3aB-4iqqA:12.7 | 5h3aB-4iqqA:58.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5J7W_C_MTXC402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 5 / 12 | ASP A 218LEU A 221GLY A 222TYR A 258ALA A 312 | D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.54A | 5j7wC-1hvyA:39.3 | 5j7wC-1hvyA:48.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5J7W_C_MTXC402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 7 / 12 | GLU A 87ILE A 108LEU A 192ASP A 218LEU A 221GLY A 222TYR A 258 | D16 A 414 (-3.8A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A) | 0.67A | 5j7wC-1hvyA:39.3 | 5j7wC-1hvyA:48.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5J7W_D_MTXD402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 12 | GLU A 87ILE A 108LEU A 192ASP A 218LEU A 221GLY A 222TYR A 258ALA A 312 | D16 A 414 (-3.8A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.85A | 5j7wD-1hvyA:39.0 | 5j7wD-1hvyA:48.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5J7W_D_MTXD402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 12 | GLU A 87ILE A 108TRP A 109LEU A 192ASP A 218GLY A 222TYR A 258ALA A 312 | D16 A 414 (-3.8A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.77A | 5j7wD-1hvyA:39.0 | 5j7wD-1hvyA:48.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5J7W_D_MTXD402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 12 | ILE A 108LEU A 192LEU A 221GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)NoneD16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 1.05A | 5j7wD-1hvyA:39.0 | 5j7wD-1hvyA:48.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5J7W_D_MTXD402_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | GLU A 89ILE A 110LEU A 223GLY A 224TYR A 260 | NoneD16 A 402 (-4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 0.86A | 5j7wD-4iqqA:35.3 | 5j7wD-4iqqA:43.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5J7W_D_MTXD402_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | GLU A 89ILE A 110TRP A 111LEU A 223GLY A 224 | NoneD16 A 402 (-4.0A)NoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A) | 0.76A | 5j7wD-4iqqA:35.3 | 5j7wD-4iqqA:43.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5J7W_D_MTXD402_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | GLU A 89TRP A 111LEU A 194LEU A 223GLY A 224 | NoneNoneNoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A) | 0.87A | 5j7wD-4iqqA:35.3 | 5j7wD-4iqqA:43.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5J7W_D_MTXD402_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ILE A 110ASP A 220LEU A 223GLY A 224TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 0.88A | 5j7wD-4iqqA:35.3 | 5j7wD-4iqqA:43.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5J7W_D_MTXD402_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 12 | GLU A 111ILE A 132TRP A 133LEU A 216GLY A 246TYR A 282 | D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)NoneNoneD16 A 401 ( 3.2A)UMP A 402 (-4.5A) | 0.89A | 5j7wD-5h3aA:35.3 | 5j7wD-5h3aA:45.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5J7W_D_MTXD402_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | ILE A 132LEU A 216ASP A 242GLY A 246TYR A 282 | D16 A 401 ( 4.0A)NoneD16 A 401 ( 4.0A)D16 A 401 ( 3.2A)UMP A 402 (-4.5A) | 1.08A | 5j7wD-5h3aA:35.3 | 5j7wD-5h3aA:45.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NOO_A_D16A402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 7 | ILE A 108ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.58A | 5nooA-1hvyA:42.1 | 5nooA-1hvyA:62.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NOO_A_D16A402_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 7 / 7 | TYR A 82ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-3.6A)D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.15A | 5nooA-4iqqA:47.3 | 5nooA-4iqqA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NOO_A_D16A402_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 7 | ILE A 132ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 0.22A | 5nooA-5h3aA:42.7 | 5nooA-5h3aA:58.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NOO_B_D16B402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 7 | ILE A 108ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.68A | 5nooB-1hvyA:41.7 | 5nooB-1hvyA:62.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NOO_B_D16B402_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 7 / 7 | TYR A 82ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-3.6A)D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.28A | 5nooB-4iqqA:46.2 | 5nooB-4iqqA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NOO_B_D16B402_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 7 | ILE A 132ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 0.28A | 5nooB-5h3aA:42.2 | 5nooB-5h3aA:58.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NOO_C_D16C402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 5 / 6 | ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258 | D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.55A | 5nooC-1hvyA:41.3 | 5nooC-1hvyA:62.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NOO_C_D16C402_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 6 | TYR A 82ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-3.6A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.16A | 5nooC-4iqqA:13.5 | 5nooC-4iqqA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NOO_C_D16C402_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 4 / 6 | ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 0.15A | 5nooC-5h3aA:41.9 | 5nooC-5h3aA:58.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NOO_D_D16D402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 8 | ARG A 78ILE A 108ASP A 218GLY A 222PHE A 225TYR A 258 | NoneD16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.85A | 5nooD-1hvyA:20.8 | 5nooD-1hvyA:62.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NOO_D_D16D402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 8 | ILE A 108ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.64A | 5nooD-1hvyA:20.8 | 5nooD-1hvyA:62.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X5Q_B_D16B402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 7 / 12 | GLU A 87ILE A 108LEU A 221GLY A 222PHE A 225MET A 311ALA A 312 | D16 A 414 (-3.8A)D16 A 414 (-3.7A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)D16 A 414 (-3.4A)D16 A 414 (-3.6A) | 0.99A | 5x5qB-1hvyA:47.1 | 5x5qB-1hvyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X5Q_B_D16B402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 12 | GLU A 87ILE A 108PHE A 225THR A 306MET A 311ALA A 312 | D16 A 414 (-3.8A)D16 A 414 (-3.7A)D16 A 414 (-3.6A)NoneD16 A 414 (-3.4A)D16 A 414 (-3.6A) | 0.99A | 5x5qB-1hvyA:47.1 | 5x5qB-1hvyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X5Q_B_D16B402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 7 / 12 | GLU A 87ILE A 108PHE A 225TYR A 258THR A 306MET A 309MET A 311 | D16 A 414 (-3.8A)D16 A 414 (-3.7A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A)NoneNoneD16 A 414 (-3.4A) | 0.71A | 5x5qB-1hvyA:47.1 | 5x5qB-1hvyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X5Q_B_D16B402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 10 / 12 | GLU A 87ILE A 108TRP A 109ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258MET A 309MET A 311 | D16 A 414 (-3.8A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A)NoneD16 A 414 (-3.4A) | 0.49A | 5x5qB-1hvyA:47.1 | 5x5qB-1hvyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X5Q_B_D16B402_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 7 / 12 | GLU A 89ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | NoneD16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.38A | 5x5qB-4iqqA:42.7 | 5x5qB-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X5Q_B_D16B402_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 7 / 12 | GLU A 111ILE A 132ASP A 242GLY A 246PHE A 249TYR A 282THR A 330 | D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A)None | 0.58A | 5x5qB-5h3aA:43.6 | 5x5qB-5h3aA:71.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X5Q_B_D16B402_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | GLU A 111ILE A 132TRP A 133PHE A 249TYR A 282 | D16 A 401 ( 4.7A)D16 A 401 ( 4.0A)NoneD16 A 401 (-3.4A)UMP A 402 (-4.5A) | 0.74A | 5x5qB-5h3aA:43.6 | 5x5qB-5h3aA:71.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X5Q_C_D16C402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 7 / 7 | PHE A 80ILE A 108ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.47A | 5x5qC-1hvyA:44.8 | 5x5qC-1hvyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X5Q_C_D16C402_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 7 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.23A | 5x5qC-4iqqA:42.8 | 5x5qC-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X5Q_C_D16C402_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 7 | PHE A 104ILE A 132ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 0.26A | 5x5qC-5h3aA:43.8 | 5x5qC-5h3aA:71.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X5Q_D_D16D402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 7 / 8 | PHE A 80ILE A 108ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.47A | 5x5qD-1hvyA:44.9 | 5x5qD-1hvyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X5Q_D_D16D402_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 8 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.24A | 5x5qD-4iqqA:13.0 | 5x5qD-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X5Q_D_D16D402_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 8 | PHE A 104ILE A 132ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 0.30A | 5x5qD-5h3aA:43.7 | 5x5qD-5h3aA:71.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X5Q_E_D16E402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 6 | PHE A 80ILE A 108ASP A 218LEU A 221GLY A 222TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A) | 0.44A | 5x5qE-1hvyA:44.7 | 5x5qE-1hvyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X5Q_E_D16E402_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 6 | ILE A 110ASP A 220LEU A 223GLY A 224TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 ( 4.2A) | 0.24A | 5x5qE-4iqqA:42.7 | 5x5qE-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X5Q_F_D16F402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 7 / 8 | PHE A 80ILE A 108ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A) | 0.49A | 5x5qF-1hvyA:44.6 | 5x5qF-1hvyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X5Q_F_D16F402_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 8 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.24A | 5x5qF-4iqqA:42.6 | 5x5qF-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X5Q_F_D16F402_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 8 | PHE A 104ILE A 132ASP A 242GLY A 246PHE A 249TYR A 282 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A) | 0.30A | 5x5qF-5h3aA:43.5 | 5x5qF-5h3aA:71.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X66_A_MTXA402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 10 / 12 | PHE A 80ILE A 108ASP A 218LEU A 221GLY A 222PHE A 225ASN A 226TYR A 258MET A 311ALA A 312 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 (-3.0A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A)D16 A 414 (-3.6A) | 0.64A | 5x66A-1hvyA:47.45x66B-1hvyA:47.7 | 5x66A-1hvyA:100.005x66B-1hvyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X66_A_MTXA402_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ASP A 220LEU A 223GLY A 224ASN A 228TYR A 260 | D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)UMP A 401 (-3.3A)D16 A 402 ( 4.2A) | 0.79A | 5x66A-4iqqA:43.35x66B-4iqqA:13.2 | 5x66A-4iqqA:62.545x66B-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X66_A_MTXA402_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 12 | ILE A 110ASP A 220GLY A 224PHE A 227ASN A 228TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)UMP A 401 (-3.3A)D16 A 402 ( 4.2A) | 0.38A | 5x66A-4iqqA:43.35x66B-4iqqA:13.2 | 5x66A-4iqqA:62.545x66B-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X66_A_MTXA402_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 7 / 12 | PHE A 104ILE A 132ASP A 242GLY A 246PHE A 249ASN A 250TYR A 282 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-3.2A)UMP A 402 (-4.5A) | 0.32A | 5x66A-5h3aA:44.15x66B-5h3aA:29.5 | 5x66A-5h3aA:71.735x66B-5h3aA:71.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X66_C_MTXC402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 9 | ILE A 108ASP A 218LEU A 221GLY A 222PHE A 225ASN A 226TYR A 258MET A 311ALA A 312 | D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 (-3.0A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A)D16 A 414 (-3.6A) | 0.49A | 5x66C-1hvyA:47.7 | 5x66C-1hvyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X66_C_MTXC402_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 7 / 9 | ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227ASN A 228TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)UMP A 401 (-3.3A)D16 A 402 ( 4.2A) | 0.61A | 5x66C-4iqqA:43.1 | 5x66C-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X66_C_MTXC402_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 9 | ILE A 132ASP A 242GLY A 246PHE A 249ASN A 250TYR A 282 | D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-3.2A)UMP A 402 (-4.5A) | 0.34A | 5x66C-5h3aA:44.0 | 5x66C-5h3aA:71.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X66_D_MTXD402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 10 | PHE A 80ILE A 108ASP A 218GLY A 222PHE A 225ASN A 226TYR A 258MET A 311ALA A 312 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 (-3.0A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A)D16 A 414 (-3.6A) | 0.41A | 5x66D-1hvyA:47.1 | 5x66D-1hvyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X66_D_MTXD402_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 10 | ILE A 110ASP A 220GLY A 224PHE A 227ASN A 228TYR A 260 | D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)UMP A 401 (-3.3A)D16 A 402 ( 4.2A) | 0.39A | 5x66D-4iqqA:42.9 | 5x66D-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X66_D_MTXD402_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 7 / 10 | PHE A 104ILE A 132ASP A 242GLY A 246PHE A 249ASN A 250TYR A 282 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-3.2A)UMP A 402 (-4.5A) | 0.35A | 5x66D-5h3aA:43.5 | 5x66D-5h3aA:71.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X66_F_MTXF402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 12 | LYS A 77ASP A 218GLY A 222TYR A 258THR A 306MET A 311ALA A 312VAL A 313 | D16 A 414 ( 4.3A)D16 A 414 ( 3.6A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A)NoneD16 A 414 (-3.4A)D16 A 414 (-3.6A)None | 1.13A | 5x66F-1hvyA:47.3 | 5x66F-1hvyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X66_F_MTXF402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 12 | LYS A 77ASP A 218LEU A 221GLY A 222TYR A 258MET A 311ALA A 312VAL A 313 | D16 A 414 ( 4.3A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A)D16 A 414 (-3.6A)None | 1.09A | 5x66F-1hvyA:47.3 | 5x66F-1hvyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X66_F_MTXF402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 10 / 12 | LYS A 77PHE A 80ILE A 108ASP A 218GLY A 222PHE A 225TYR A 258THR A 306MET A 311ALA A 312 | D16 A 414 ( 4.3A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A)NoneD16 A 414 (-3.4A)D16 A 414 (-3.6A) | 0.60A | 5x66F-1hvyA:47.3 | 5x66F-1hvyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X66_F_MTXF402_1 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 10 / 12 | LYS A 77PHE A 80ILE A 108ASP A 218LEU A 221GLY A 222PHE A 225TYR A 258MET A 311ALA A 312 | D16 A 414 ( 4.3A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A)D16 A 414 (-3.6A) | 0.53A | 5x66F-1hvyA:47.3 | 5x66F-1hvyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X66_F_MTXF402_1 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 7 / 12 | LYS A 79ILE A 110ASP A 220LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 ( 4.5A)D16 A 402 (-4.0A)D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 0.93A | 5x66F-4iqqA:42.9 | 5x66F-4iqqA:62.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X66_F_MTXF402_1 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 7 / 12 | PHE A 104ILE A 132ASP A 242GLY A 246PHE A 249TYR A 282THR A 330 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-4.5A)None | 0.47A | 5x66F-5h3aA:43.5 | 5x66F-5h3aA:71.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6F32_B_ACTB602_0 (AMINE OXIDASE LKCE) |
5a6b | N-ACETYL-BETA-D-GLUCOSAMINIDASE (Streptococcuspneumoniae) | 4 / 6 | TYR D 308VAL D 368VAL D 370THR D 371 | OAN D1627 (-4.3A)NoneNoneNone | 1.33A | 6f32B-5a6bD:undetectable | 6f32B-5a6bD:23.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QXS_B_FOZB403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 7 / 12 | ILE A 108LEU A 192LEU A 221GLY A 222PHE A 225ASN A 226TYR A 258 | D16 A 414 (-3.7A)NoneD16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 (-3.0A)UMP A 314 ( 4.4A) | 1.10A | 6qxsB-1hvyA:38.5 | 6qxsB-1hvyA:48.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QXS_B_FOZB403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 12 | ILE A 108TRP A 109LEU A 192GLY A 222ASN A 226TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 (-3.3A)UMP A 314 (-3.0A)UMP A 314 ( 4.4A) | 0.77A | 6qxsB-1hvyA:38.5 | 6qxsB-1hvyA:48.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QXS_B_FOZB403_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 12 | ILE A 110LEU A 223GLY A 224PHE A 227ASN A 228TYR A 260 | D16 A 402 (-4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)UMP A 401 (-3.3A)D16 A 402 ( 4.2A) | 1.08A | 6qxsB-4iqqA:35.0 | 6qxsB-4iqqA:43.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QXS_B_FOZB403_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 12 | ILE A 110TRP A 111LEU A 223GLY A 224PHE A 227ASN A 228 | D16 A 402 (-4.0A)NoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)UMP A 401 (-3.3A) | 1.13A | 6qxsB-4iqqA:35.0 | 6qxsB-4iqqA:43.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QXS_B_FOZB403_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | TRP A 111LEU A 194LEU A 223GLY A 224ASN A 228 | NoneNoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)UMP A 401 (-3.3A) | 0.83A | 6qxsB-4iqqA:35.0 | 6qxsB-4iqqA:43.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QXS_B_FOZB403_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | ILE A 132LEU A 216GLY A 246ASN A 250TYR A 282 | D16 A 401 ( 4.0A)NoneD16 A 401 ( 3.2A)UMP A 402 (-3.2A)UMP A 402 (-4.5A) | 0.95A | 6qxsB-5h3aA:34.8 | 6qxsB-5h3aA:45.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QXS_B_FOZB403_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | ILE A 132TRP A 133LEU A 216GLY A 246ASN A 250 | D16 A 401 ( 4.0A)NoneNoneD16 A 401 ( 3.2A)UMP A 402 (-3.2A) | 0.68A | 6qxsB-5h3aA:34.8 | 6qxsB-5h3aA:45.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QXS_D_FOZD403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 5 / 12 | ILE A 108ASP A 218GLY A 222ASN A 226ALA A 312 | D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-3.3A)UMP A 314 (-3.0A)D16 A 414 (-3.6A) | 0.63A | 6qxsD-1hvyA:38.4 | 6qxsD-1hvyA:48.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QXS_D_FOZD403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 5 / 12 | ILE A 108ASP A 218LEU A 221GLY A 222ALA A 312 | D16 A 414 (-3.7A)D16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A) | 0.79A | 6qxsD-1hvyA:38.4 | 6qxsD-1hvyA:48.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QXS_D_FOZD403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 12 | ILE A 108TRP A 109LEU A 192ASP A 218GLY A 222ASN A 226 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-3.3A)UMP A 314 (-3.0A) | 0.73A | 6qxsD-1hvyA:38.4 | 6qxsD-1hvyA:48.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QXS_D_FOZD403_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | ILE A 132TRP A 133LEU A 216GLY A 246ASN A 250 | D16 A 401 ( 4.0A)NoneNoneD16 A 401 ( 3.2A)UMP A 402 (-3.2A) | 0.55A | 6qxsD-5h3aA:34.7 | 6qxsD-5h3aA:45.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QYA_B_FOZB401_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 5 / 12 | ILE A 108LEU A 221GLY A 222TYR A 258ALA A 312 | D16 A 414 (-3.7A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.72A | 6qyaB-1hvyA:37.9 | 6qyaB-1hvyA:48.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QYA_B_FOZB401_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 5 / 12 | ILE A 108TRP A 109LEU A 192GLY A 222TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 (-3.3A)UMP A 314 ( 4.4A) | 0.69A | 6qyaB-1hvyA:37.9 | 6qyaB-1hvyA:48.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QYA_B_FOZB401_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ILE A 110LEU A 223GLY A 224PHE A 227TYR A 260 | D16 A 402 (-4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)D16 A 402 ( 4.2A) | 1.09A | 6qyaB-4iqqA:34.6 | 6qyaB-4iqqA:43.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QYA_D_FOZD401_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 5 / 12 | ILE A 108GLY A 222ASN A 226TYR A 258ALA A 312 | D16 A 414 (-3.7A)D16 A 414 (-3.3A)UMP A 314 (-3.0A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.59A | 6qyaD-1hvyA:37.9 | 6qyaD-1hvyA:48.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QYA_D_FOZD401_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 5 / 12 | ILE A 108LEU A 221GLY A 222TYR A 258ALA A 312 | D16 A 414 (-3.7A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 ( 4.4A)D16 A 414 (-3.6A) | 0.73A | 6qyaD-1hvyA:37.9 | 6qyaD-1hvyA:48.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QYA_D_FOZD401_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 6 / 12 | ILE A 108TRP A 109LEU A 192GLY A 222ASN A 226TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 (-3.3A)UMP A 314 (-3.0A)UMP A 314 ( 4.4A) | 0.69A | 6qyaD-1hvyA:37.9 | 6qyaD-1hvyA:48.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QYA_D_FOZD401_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ILE A 110HIS A 198GLY A 224ASN A 228TYR A 260 | D16 A 402 (-4.0A)UMP A 401 ( 4.7A)D16 A 402 ( 3.1A)UMP A 401 (-3.3A)D16 A 402 ( 4.2A) | 0.57A | 6qyaD-4iqqA:34.6 | 6qyaD-4iqqA:43.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QYA_D_FOZD401_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ILE A 110TRP A 111HIS A 198GLY A 224ASN A 228 | D16 A 402 (-4.0A)NoneUMP A 401 ( 4.7A)D16 A 402 ( 3.1A)UMP A 401 (-3.3A) | 0.49A | 6qyaD-4iqqA:34.6 | 6qyaD-4iqqA:43.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QYA_D_FOZD401_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | TRP A 111LEU A 194HIS A 198GLY A 224ASN A 228 | NoneNoneUMP A 401 ( 4.7A)D16 A 402 ( 3.1A)UMP A 401 (-3.3A) | 0.61A | 6qyaD-4iqqA:34.6 | 6qyaD-4iqqA:43.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QYA_D_FOZD401_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | ILE A 132TRP A 133LEU A 216GLY A 246ASN A 250 | D16 A 401 ( 4.0A)NoneNoneD16 A 401 ( 3.2A)UMP A 402 (-3.2A) | 0.62A | 6qyaD-5h3aA:34.5 | 6qyaD-5h3aA:45.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QYA_D_FOZD401_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | ILE A 132TRP A 133LEU A 216HIS A 220ASN A 250 | D16 A 401 ( 4.0A)NoneNoneUMP A 402 (-3.9A)UMP A 402 (-3.2A) | 0.78A | 6qyaD-5h3aA:34.5 | 6qyaD-5h3aA:45.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_A_FFOA403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 10 / 12 | PHE A 80ILE A 108ASN A 112LEU A 192ASP A 218LEU A 221GLY A 222PHE A 225ASN A 226TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 (-3.0A)UMP A 314 ( 4.4A) | 0.88A | 6r2eA-1hvyA:47.3 | 6r2eA-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_A_FFOA403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 12 | PHE A 80ILE A 108LEU A 192ASP A 218GLY A 222PHE A 225ASN A 226TYR A 258MET A 311 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 (-3.0A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A) | 0.97A | 6r2eA-1hvyA:47.3 | 6r2eA-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_A_FFOA403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 10 / 12 | PHE A 80ILE A 108TRP A 109ASN A 112LEU A 192ASP A 218LEU A 221GLY A 222ASN A 226TYR A 258 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 (-3.0A)UMP A 314 ( 4.4A) | 0.69A | 6r2eA-1hvyA:47.3 | 6r2eA-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_A_FFOA403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 12 | PHE A 80ILE A 108TRP A 109LEU A 192ASP A 218GLY A 222ASN A 226TYR A 258MET A 311 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-3.3A)UMP A 314 (-3.0A)UMP A 314 ( 4.4A)D16 A 414 (-3.4A) | 0.76A | 6r2eA-1hvyA:47.3 | 6r2eA-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_A_FFOA403_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ASP A 220LEU A 223GLY A 224ASN A 228TYR A 260 | D16 A 402 ( 4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)UMP A 401 (-3.3A)D16 A 402 ( 4.2A) | 0.76A | 6r2eA-4iqqA:41.7 | 6r2eA-4iqqA:60.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_A_FFOA403_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 12 | ILE A 110LEU A 223GLY A 224PHE A 227ASN A 228TYR A 260 | D16 A 402 (-4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)UMP A 401 (-3.3A)D16 A 402 ( 4.2A) | 0.97A | 6r2eA-4iqqA:41.7 | 6r2eA-4iqqA:60.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_A_FFOA403_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 7 / 12 | ILE A 110TRP A 111ASN A 114LEU A 194GLY A 224PHE A 227ASN A 228 | D16 A 402 (-4.0A)NoneNoneNoneD16 A 402 ( 3.1A)D16 A 402 (-3.2A)UMP A 401 (-3.3A) | 1.18A | 6r2eA-4iqqA:41.7 | 6r2eA-4iqqA:60.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_A_FFOA403_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 7 / 12 | ILE A 110TRP A 111LEU A 194LEU A 223GLY A 224PHE A 227ASN A 228 | D16 A 402 (-4.0A)NoneNoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)UMP A 401 (-3.3A) | 1.24A | 6r2eA-4iqqA:41.7 | 6r2eA-4iqqA:60.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_A_FFOA403_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 12 | ILE A 132TRP A 133ASN A 136LEU A 216PHE A 249ASN A 250 | D16 A 401 ( 4.0A)NoneNoneNoneD16 A 401 (-3.4A)UMP A 402 (-3.2A) | 1.10A | 6r2eA-5h3aA:42.5 | 6r2eA-5h3aA:71.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_A_FFOA403_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 12 | ILE A 132TRP A 133LEU A 216GLY A 246PHE A 249ASN A 250 | D16 A 401 ( 4.0A)NoneNoneD16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-3.2A) | 1.18A | 6r2eA-5h3aA:42.5 | 6r2eA-5h3aA:71.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_A_FFOA403_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 12 | PHE A 104ASP A 242GLY A 246ASN A 250TYR A 282 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)UMP A 402 (-3.2A)UMP A 402 (-4.5A) | 0.60A | 6r2eA-5h3aA:42.5 | 6r2eA-5h3aA:71.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_A_FFOA403_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 12 | PHE A 104ILE A 132GLY A 246PHE A 249ASN A 250TYR A 282 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)D16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-3.2A)UMP A 402 (-4.5A) | 1.18A | 6r2eA-5h3aA:42.5 | 6r2eA-5h3aA:71.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_A_FFOA403_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 12 | PHE A 104ILE A 132TRP A 133ASN A 136PHE A 249ASN A 250 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)NoneNoneD16 A 401 (-3.4A)UMP A 402 (-3.2A) | 1.22A | 6r2eA-5h3aA:42.5 | 6r2eA-5h3aA:71.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_A_FFOA403_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 12 | PHE A 104ILE A 132TRP A 133GLY A 246PHE A 249ASN A 250 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)NoneD16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-3.2A) | 1.24A | 6r2eA-5h3aA:42.5 | 6r2eA-5h3aA:71.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_B_FFOB403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 10 / 10 | PHE A 80ILE A 108TRP A 109ASN A 112LEU A 192ASP A 218LEU A 221GLY A 222ASN A 226MET A 311 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 (-3.0A)D16 A 414 (-3.4A) | 0.71A | 6r2eB-1hvyA:46.6 | 6r2eB-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_B_FFOB403_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 10 | ILE A 110TRP A 111ASN A 114LEU A 194GLY A 224ASN A 228 | D16 A 402 (-4.0A)NoneNoneNoneD16 A 402 ( 3.1A)UMP A 401 (-3.3A) | 0.91A | 6r2eB-4iqqA:41.4 | 6r2eB-4iqqA:60.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_B_FFOB403_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 10 | ILE A 110TRP A 111LEU A 194LEU A 223GLY A 224ASN A 228 | D16 A 402 (-4.0A)NoneNoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)UMP A 401 (-3.3A) | 1.03A | 6r2eB-4iqqA:41.4 | 6r2eB-4iqqA:60.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_B_FFOB403_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 10 | ILE A 132TRP A 133ASN A 136LEU A 216GLY A 246ASN A 250 | D16 A 401 ( 4.0A)NoneNoneNoneD16 A 401 ( 3.2A)UMP A 402 (-3.2A) | 0.85A | 6r2eB-5h3aA:42.1 | 6r2eB-5h3aA:71.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_B_FFOB403_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 10 | PHE A 104ILE A 132TRP A 133GLY A 246ASN A 250 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)NoneD16 A 401 ( 3.2A)UMP A 402 (-3.2A) | 0.84A | 6r2eB-5h3aA:42.1 | 6r2eB-5h3aA:71.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_C_FFOC404_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 10 | PHE A 80ILE A 108TRP A 109ASN A 112LEU A 192ASP A 218LEU A 221GLY A 222ASN A 226 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 (-3.0A) | 0.59A | 6r2eC-1hvyA:47.3 | 6r2eC-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_C_FFOC404_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 10 | PHE A 80ILE A 108TRP A 109LEU A 192ASP A 218LEU A 221GLY A 222ASN A 226MET A 311 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 (-3.0A)D16 A 414 (-3.4A) | 0.76A | 6r2eC-1hvyA:47.3 | 6r2eC-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_C_FFOC404_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 10 | ILE A 110TRP A 111ASN A 114LEU A 194GLY A 224ASN A 228 | D16 A 402 (-4.0A)NoneNoneNoneD16 A 402 ( 3.1A)UMP A 401 (-3.3A) | 0.94A | 6r2eC-4iqqA:41.7 | 6r2eC-4iqqA:60.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_C_FFOC404_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 10 | ILE A 110TRP A 111LEU A 194LEU A 223GLY A 224ASN A 228 | D16 A 402 (-4.0A)NoneNoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)UMP A 401 (-3.3A) | 1.04A | 6r2eC-4iqqA:41.7 | 6r2eC-4iqqA:60.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_C_FFOC404_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 10 | ILE A 132TRP A 133ASN A 136LEU A 216GLY A 246ASN A 250 | D16 A 401 ( 4.0A)NoneNoneNoneD16 A 401 ( 3.2A)UMP A 402 (-3.2A) | 0.85A | 6r2eC-5h3aA:42.5 | 6r2eC-5h3aA:71.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_C_FFOC404_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 10 | PHE A 104ILE A 132TRP A 133GLY A 246ASN A 250 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)NoneD16 A 401 ( 3.2A)UMP A 402 (-3.2A) | 0.85A | 6r2eC-5h3aA:42.5 | 6r2eC-5h3aA:71.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_D_FFOD403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 10 | PHE A 80ILE A 108TRP A 109ASN A 112LEU A 192ASP A 218GLY A 222ASN A 226MET A 311 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)NoneD16 A 414 ( 3.6A)D16 A 414 (-3.3A)UMP A 314 (-3.0A)D16 A 414 (-3.4A) | 0.74A | 6r2eD-1hvyA:46.7 | 6r2eD-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_D_FFOD403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 10 | PHE A 80ILE A 108TRP A 109ASN A 112LEU A 192ASP A 218LEU A 221GLY A 222ASN A 226 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 (-3.0A) | 0.62A | 6r2eD-1hvyA:46.7 | 6r2eD-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_D_FFOD403_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 7 / 10 | ILE A 110TRP A 111ASN A 114LEU A 194LEU A 223GLY A 224ASN A 228 | D16 A 402 (-4.0A)NoneNoneNoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)UMP A 401 (-3.3A) | 0.93A | 6r2eD-4iqqA:41.5 | 6r2eD-4iqqA:60.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_D_FFOD403_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 10 | ILE A 132TRP A 133ASN A 136LEU A 216GLY A 246ASN A 250 | D16 A 401 ( 4.0A)NoneNoneNoneD16 A 401 ( 3.2A)UMP A 402 (-3.2A) | 0.79A | 6r2eD-5h3aA:42.2 | 6r2eD-5h3aA:71.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_D_FFOD403_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 10 | PHE A 104ILE A 132TRP A 133GLY A 246ASN A 250 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)NoneD16 A 401 ( 3.2A)UMP A 402 (-3.2A) | 0.85A | 6r2eD-5h3aA:42.2 | 6r2eD-5h3aA:71.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_E_FFOE403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 12 | PHE A 80ILE A 108ASN A 112TYR A 135LEU A 192GLY A 222PHE A 225ASN A 226MET A 311 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)NoneNoneD16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 (-3.0A)D16 A 414 (-3.4A) | 1.02A | 6r2eE-1hvyA:47.2 | 6r2eE-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_E_FFOE403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 12 | PHE A 80ILE A 108ASN A 112TYR A 135LEU A 192LEU A 221GLY A 222PHE A 225ASN A 226 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)NoneNoneD16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 (-3.0A) | 0.84A | 6r2eE-1hvyA:47.2 | 6r2eE-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_E_FFOE403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 12 | PHE A 80ILE A 108TRP A 109ASN A 112TYR A 135LEU A 192GLY A 222ASN A 226MET A 311 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)NoneNoneD16 A 414 (-3.3A)UMP A 314 (-3.0A)D16 A 414 (-3.4A) | 0.80A | 6r2eE-1hvyA:47.2 | 6r2eE-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_E_FFOE403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 12 | PHE A 80ILE A 108TRP A 109ASN A 112TYR A 135LEU A 192LEU A 221GLY A 222ASN A 226 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)NoneNoneD16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 (-3.0A) | 0.60A | 6r2eE-1hvyA:47.2 | 6r2eE-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_E_FFOE403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 12 | PHE A 80ILE A 108TRP A 109TYR A 135LEU A 192GLY A 222ASN A 226MET A 311ALA A 312 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneNoneD16 A 414 (-3.3A)UMP A 314 (-3.0A)D16 A 414 (-3.4A)D16 A 414 (-3.6A) | 0.84A | 6r2eE-1hvyA:47.2 | 6r2eE-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_E_FFOE403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 12 | PHE A 80ILE A 108TRP A 109TYR A 135LEU A 192LEU A 221GLY A 222ASN A 226ALA A 312 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneNoneD16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 (-3.0A)D16 A 414 (-3.6A) | 0.76A | 6r2eE-1hvyA:47.2 | 6r2eE-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_E_FFOE403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 12 | PHE A 80ILE A 108TYR A 135LEU A 192GLY A 222PHE A 225ASN A 226MET A 311ALA A 312 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneNoneD16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 (-3.0A)D16 A 414 (-3.4A)D16 A 414 (-3.6A) | 1.06A | 6r2eE-1hvyA:47.2 | 6r2eE-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_E_FFOE403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 12 | PHE A 80ILE A 108TYR A 135LEU A 192LEU A 221GLY A 222PHE A 225ASN A 226ALA A 312 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneNoneD16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 (-3.0A)D16 A 414 (-3.6A) | 0.98A | 6r2eE-1hvyA:47.2 | 6r2eE-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_E_FFOE403_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ILE A 110ASN A 114GLY A 224PHE A 227ASN A 228 | D16 A 402 (-4.0A)NoneD16 A 402 ( 3.1A)D16 A 402 (-3.2A)UMP A 401 (-3.3A) | 1.10A | 6r2eE-4iqqA:41.6 | 6r2eE-4iqqA:60.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_E_FFOE403_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 12 | ILE A 110ASN A 114TYR A 137LEU A 194GLY A 224ASN A 228 | D16 A 402 (-4.0A)NoneNoneNoneD16 A 402 ( 3.1A)UMP A 401 (-3.3A) | 0.83A | 6r2eE-4iqqA:41.6 | 6r2eE-4iqqA:60.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_E_FFOE403_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ILE A 110LEU A 223GLY A 224PHE A 227ASN A 228 | D16 A 402 (-4.0A)D16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)UMP A 401 (-3.3A) | 0.97A | 6r2eE-4iqqA:41.6 | 6r2eE-4iqqA:60.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_E_FFOE403_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ILE A 110TRP A 111ASN A 114PHE A 227ASN A 228 | D16 A 402 (-4.0A)NoneNoneD16 A 402 (-3.2A)UMP A 401 (-3.3A) | 1.09A | 6r2eE-4iqqA:41.6 | 6r2eE-4iqqA:60.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_E_FFOE403_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 12 | ILE A 110TRP A 111ASN A 114TYR A 137LEU A 194ASN A 228 | D16 A 402 (-4.0A)NoneNoneNoneNoneUMP A 401 (-3.3A) | 0.74A | 6r2eE-4iqqA:41.6 | 6r2eE-4iqqA:60.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_E_FFOE403_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 5 / 12 | ILE A 110TRP A 111LEU A 223PHE A 227ASN A 228 | D16 A 402 (-4.0A)NoneD16 A 402 (-3.7A)D16 A 402 (-3.2A)UMP A 401 (-3.3A) | 1.17A | 6r2eE-4iqqA:41.6 | 6r2eE-4iqqA:60.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_E_FFOE403_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 12 | ILE A 110TRP A 111TYR A 137LEU A 194LEU A 223ASN A 228 | D16 A 402 (-4.0A)NoneNoneNoneD16 A 402 (-3.7A)UMP A 401 (-3.3A) | 0.90A | 6r2eE-4iqqA:41.6 | 6r2eE-4iqqA:60.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_E_FFOE403_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 6 / 12 | ILE A 110TYR A 137LEU A 194LEU A 223GLY A 224ASN A 228 | D16 A 402 (-4.0A)NoneNoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)UMP A 401 (-3.3A) | 0.90A | 6r2eE-4iqqA:41.6 | 6r2eE-4iqqA:60.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_E_FFOE403_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 7 / 12 | ILE A 132TRP A 133ASN A 136LEU A 216GLY A 246PHE A 249ASN A 250 | D16 A 401 ( 4.0A)NoneNoneNoneD16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-3.2A) | 1.13A | 6r2eE-5h3aA:42.5 | 6r2eE-5h3aA:71.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_E_FFOE403_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 7 / 12 | ILE A 132TRP A 133ASN A 136TYR A 159LEU A 216GLY A 246ASN A 250 | D16 A 401 ( 4.0A)NoneNoneNoneNoneD16 A 401 ( 3.2A)UMP A 402 (-3.2A) | 0.84A | 6r2eE-5h3aA:42.5 | 6r2eE-5h3aA:71.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_E_FFOE403_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 12 | PHE A 104ILE A 132TRP A 133GLY A 246PHE A 249ASN A 250 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)NoneD16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-3.2A) | 1.32A | 6r2eE-5h3aA:42.5 | 6r2eE-5h3aA:71.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_E_FFOE403_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 12 | PHE A 104ILE A 132TRP A 133TYR A 159GLY A 246ASN A 250 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)NoneNoneD16 A 401 ( 3.2A)UMP A 402 (-3.2A) | 0.93A | 6r2eE-5h3aA:42.5 | 6r2eE-5h3aA:71.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_F_FFOF403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 10 / 11 | PHE A 80ILE A 108TRP A 109ASN A 112LEU A 192ASP A 218LEU A 221GLY A 222ASN A 226MET A 311 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 (-3.0A)D16 A 414 (-3.4A) | 0.79A | 6r2eF-1hvyA:46.9 | 6r2eF-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_F_FFOF403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 10 / 11 | PHE A 80ILE A 108TRP A 109LEU A 192ASP A 218LEU A 221GLY A 222ASN A 226MET A 311ALA A 312 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 (-3.0A)D16 A 414 (-3.4A)D16 A 414 (-3.6A) | 0.82A | 6r2eF-1hvyA:46.9 | 6r2eF-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_F_FFOF403_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 7 / 11 | ILE A 110TRP A 111ASN A 114LEU A 194LEU A 223GLY A 224ASN A 228 | D16 A 402 (-4.0A)NoneNoneNoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)UMP A 401 (-3.3A) | 0.95A | 6r2eF-4iqqA:41.5 | 6r2eF-4iqqA:60.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_F_FFOF403_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 11 | ILE A 132TRP A 133ASN A 136LEU A 216GLY A 246ASN A 250 | D16 A 401 ( 4.0A)NoneNoneNoneD16 A 401 ( 3.2A)UMP A 402 (-3.2A) | 0.78A | 6r2eF-5h3aA:42.3 | 6r2eF-5h3aA:71.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_F_FFOF403_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 5 / 11 | PHE A 104ILE A 132TRP A 133GLY A 246ASN A 250 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)NoneD16 A 401 ( 3.2A)UMP A 402 (-3.2A) | 0.80A | 6r2eF-5h3aA:42.3 | 6r2eF-5h3aA:71.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_G_FFOG403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 11 | PHE A 80ILE A 108ASN A 112LEU A 192ASP A 218LEU A 221GLY A 222PHE A 225ASN A 226 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 (-3.0A) | 0.84A | 6r2eG-1hvyA:47.1 | 6r2eG-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_G_FFOG403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 11 | PHE A 80ILE A 108LEU A 192ASP A 218GLY A 222PHE A 225ASN A 226MET A 311 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-3.3A)D16 A 414 (-3.6A)UMP A 314 (-3.0A)D16 A 414 (-3.4A) | 1.00A | 6r2eG-1hvyA:47.1 | 6r2eG-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_G_FFOG403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 9 / 11 | PHE A 80ILE A 108TRP A 109ASN A 112LEU A 192ASP A 218LEU A 221GLY A 222ASN A 226 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 (-3.0A) | 0.61A | 6r2eG-1hvyA:47.1 | 6r2eG-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_G_FFOG403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 8 / 11 | PHE A 80ILE A 108TRP A 109LEU A 192ASP A 218GLY A 222ASN A 226MET A 311 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-3.3A)UMP A 314 (-3.0A)D16 A 414 (-3.4A) | 0.76A | 6r2eG-1hvyA:47.1 | 6r2eG-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_G_FFOG403_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 7 / 11 | ILE A 110TRP A 111ASN A 114LEU A 194LEU A 223GLY A 224ASN A 228 | D16 A 402 (-4.0A)NoneNoneNoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)UMP A 401 (-3.3A) | 0.98A | 6r2eG-4iqqA:41.5 | 6r2eG-4iqqA:60.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_G_FFOG403_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 7 / 11 | ILE A 110TRP A 111ASN A 114LEU A 223GLY A 224PHE A 227ASN A 228 | D16 A 402 (-4.0A)NoneNoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)D16 A 402 (-3.2A)UMP A 401 (-3.3A) | 1.13A | 6r2eG-4iqqA:41.5 | 6r2eG-4iqqA:60.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_G_FFOG403_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 7 / 11 | ILE A 132TRP A 133ASN A 136LEU A 216GLY A 246PHE A 249ASN A 250 | D16 A 401 ( 4.0A)NoneNoneNoneD16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-3.2A) | 1.11A | 6r2eG-5h3aA:42.6 | 6r2eG-5h3aA:71.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_G_FFOG403_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 11 | PHE A 104ILE A 132TRP A 133GLY A 246PHE A 249ASN A 250 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)NoneD16 A 401 ( 3.2A)D16 A 401 (-3.4A)UMP A 402 (-3.2A) | 1.26A | 6r2eG-5h3aA:42.6 | 6r2eG-5h3aA:71.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_H_FFOH403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 10 / 12 | PHE A 80ILE A 108TRP A 109ASN A 112TYR A 135LEU A 192ASP A 218LEU A 221GLY A 222ASN A 226 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 ( 4.0A)NoneNoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 (-3.0A) | 0.76A | 6r2eH-1hvyA:46.8 | 6r2eH-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_H_FFOH403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 10 / 12 | PHE A 80ILE A 108TRP A 109LEU A 192ASP A 218LEU A 221GLY A 222ASN A 226MET A 311ALA A 312 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 (-3.0A)D16 A 414 (-3.4A)D16 A 414 (-3.6A) | 0.87A | 6r2eH-1hvyA:46.8 | 6r2eH-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_H_FFOH403_0 (THYMIDYLATE SYNTHASE) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 10 / 12 | PHE A 80ILE A 108TRP A 109TYR A 135LEU A 192ASP A 218LEU A 221GLY A 222ASN A 226MET A 311 | D16 A 414 (-3.7A)D16 A 414 (-3.7A)D16 A 414 (-3.7A)NoneNoneD16 A 414 ( 3.6A)D16 A 414 (-4.0A)D16 A 414 (-3.3A)UMP A 314 (-3.0A)D16 A 414 (-3.4A) | 0.89A | 6r2eH-1hvyA:46.8 | 6r2eH-1hvyA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_H_FFOH403_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 7 / 12 | ILE A 110TRP A 111ASN A 114TYR A 137LEU A 194GLY A 224ASN A 228 | D16 A 402 (-4.0A)NoneNoneNoneNoneD16 A 402 ( 3.1A)UMP A 401 (-3.3A) | 0.89A | 6r2eH-4iqqA:41.5 | 6r2eH-4iqqA:60.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_H_FFOH403_0 (THYMIDYLATE SYNTHASE) |
4iqq | THYMIDYLATE SYNTHASE (Caenorhabditiselegans) | 7 / 12 | ILE A 110TRP A 111TYR A 137LEU A 194LEU A 223GLY A 224ASN A 228 | D16 A 402 (-4.0A)NoneNoneNoneD16 A 402 (-3.7A)D16 A 402 ( 3.1A)UMP A 401 (-3.3A) | 0.99A | 6r2eH-4iqqA:41.5 | 6r2eH-4iqqA:60.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_H_FFOH403_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 7 / 12 | ILE A 132TRP A 133ASN A 136TYR A 159LEU A 216GLY A 246ASN A 250 | D16 A 401 ( 4.0A)NoneNoneNoneNoneD16 A 401 ( 3.2A)UMP A 402 (-3.2A) | 0.89A | 6r2eH-5h3aA:42.3 | 6r2eH-5h3aA:71.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_H_FFOH403_0 (THYMIDYLATE SYNTHASE) |
5h3a | ORF70 (Humangammaherpesvirus8) | 6 / 12 | PHE A 104ILE A 132TRP A 133TYR A 159GLY A 246ASN A 250 | D16 A 401 (-3.6A)D16 A 401 ( 4.0A)NoneNoneD16 A 401 ( 3.2A)UMP A 402 (-3.2A) | 0.87A | 6r2eH-5h3aA:42.3 | 6r2eH-5h3aA:71.38 |